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Summary 
Epigenetic mechanisms control a multitude of processes in mammalian development such as 
X-chromosome inactivation, genomic imprinting and cellular differentiation, but if 
misregulated they also cause diseases as cancer. Complex molecular networks regulate 
patterns of DNA methylation and histone modifications that give rise to distinct gene 
expression profiles. 
In this study we analyzed the family of DNA methyltransferases (Dnmts) that are responsible 
for the establishment and maintenance of DNA methylation patterns. To elucidate their role 
and regulation in the epigenetic protein network we identified and characterized intra- and 
intermolecular interactions of Dnmts. For this purpose, we first developed a fast and robust 
alanine scanning mutagenesis method that allowed the streamlined generation of point, 
deletion and insertion mutants and the establishment of a Dnmt protein variant library as 
basis for further analysis. 
As the methyltransferase activity of Dnmt1 requires allosteric activation of the C-terminal 
catalytic domain through its regulatory N-terminal domain, we determined the relevant 
regions for this interaction within the N-terminal domain. While the CXXC zinc finger (amino 
acids (aa) 648-694) and phosphorylation of serine 515 were dispensable, a major part of the 
N-terminal regulatory domain was necessary for interaction with the catalytic domain. These 
results point to the importance of structural integrity of the regulatory domain for allosteric 
activation of Dnmt1. Moreover, we observed that Dnmt1 forms stable dimers through its N-
terminal regulatory domain. Mutational analyses mapped the dimerization domain to a 
bipartite interaction surface in the targeting sequence domain (TS, aa 310-629) that is also 
known to be responsible for recruiting Dnmt1 to heterochromatin. 
Similar to the targeted disruption of the dnmt1 gene, knockout of Np95 was reported to 
result in global hypomethylation in ES cells (ESCs). Therefore, we examined the role of Np95 
in the regulation of DNA methylation. We mapped and characterized the interaction between 
Dnmt1 and Np95 and found that the TS domain of Dnmt1 mediates this interaction and a 
small deletion within the highly conserved core region of the TS domain abolished the 
interaction with Np95. This Np95 interaction mutant showed catalytic activity on 
oligonucleotide DNA in a radioactive methyltransferase assay. However, it failed to restore 
methylation patterns in dnmt1-/- ESCs. These results indicate that Np95 facilitates access of 
Dnmt1 to DNA target sites in chromatin. 
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In addition, we found an interaction of Np95 with the N-terminal domains of the de novo 
DNA methyltransferases Dnmt3a and Dnmt3b which is even stronger than the interaction 
with Dnmt1. Interestingly, we observed no transgene silencing in np95-/- or dnmt1-/-3a-/-3b-/- 
(TKO) ESCs in contrast to wildtype or dnmt1-/- ESCs indicating that both, Np95 and the de 
novo DNA methyltransferases are required for promoter silencing in ESCs. These results 
assign a crucial role to Np95 in epigenetic silencing and make it an interesting target for 
epigenetic reprogramming. 
 
 
 
 
 
In summary, we developed a versatile mutagenesis strategy that allows 
efficient generation of protein variant libraries. We mapped and 
characterized intra- and intermolecular interactions of DNA 
methyltransferases. The TS domain of Dnmt1 that is located in the center of 
the N-terminus harbors several regulatory functions: It is necessary for 
allosteric activation of the catalytic domain, mediates dimerization of 
Dnmt1 and its interaction with Np95 recruits Dnmt1 to pericentric 
heterochromatin. Beside a complex regulation of Dnmts through 
interactions within the Dnmt family, other chromatin factors such as Np95 
function as key regulators for DNA methylation. 
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1. Introduction 
Epigenetics is defined as the study of heritable changes in genome function that occur 
without a change in DNA sequence. Epigenetic mechanisms are responsible for numerous 
processes during development such as X-chromosome inactivation, imprinting and cellular 
differentiation but missregulation can lead to diseases as cancer. A highly complex interplay 
between chromatin modifying proteins generates distinct patterns of histone modifications 
and DNA methylation that give rise to specific gene expression profiles. To date, many 
epigenetic factors that establish, maintain and change the epigenetic landscape in the 
nucleus have been identified. However, the spatial and temporal coordination of this 
epigenetic protein network is not yet understood in detail. DNA methylation at CpG 
dinucleotides is a crucial epigenetic modification associated with gene silencing. We study 
the role and regulation of the DNA methyltransferase family that establishes and maintains 
DNA methylation patterns to elucidate the underlying mechanisms. 
The aim of this study is a detailed biochemical and cell biological analysis of DNA 
methyltransferases, focusing on the maintenance DNA methyltransferase1 (Dnmt1), to 
achieve a better comprehension of the regulation of DNA methyltransferases within the 
epigenetic protein network. The first goal of this study was the development of a fast and 
reliable mutagenesis method that allows mapping of interacting protein regions from protein 
domains to single amino acids. Consequently, specific interaction mutants can be 
characterized to determine their functional consequences. The second objective was a 
detailed biochemical analysis of Dnmt1 to identify and characterize intramolecular and 
intermolecular interactions that regulate the enzyme. Dnmt1 contains a unique regulatory N-
terminal domain. The intramolecular interaction between the regulatory N-terminal domain 
and the catalytic C-terminal domain is indispensable for the allosteric activation of Dnmt1. 
Therefore, we determined the parts of this N-terminal domain that are necessary for N-C-
terminal interaction and hence Dnmt1 catalytic activity. Moreover, biochemical analysis of 
Dnmt1 revealed that Dnmt1 forms stable dimers via the central part of the N-terminal 
regulatory domain. Third, we aimed for the identification and characterization of new 
interaction partners of DNA methyltransferases. We found that Np95 interacts not only with 
the maintenance DNA methyltransferase1 but also with the de novo DNA 
methyltransferases3a and 3b and functions as key regulator of DNA methylation. 
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1.1  Protein-Protein Interactions 
Protein-protein interactions play a central role in biological processes such as DNA 
replication, transcription, translation, splicing, secretion, cell cycle control or signal 
transduction. To understand the molecular mechanisms regulating the establishment and 
maintenance of DNA methylation, we study the protein network around DNA 
methyltransferases. Taking advantage of various methods, we identify interacting proteins, 
map interacting domains and respective amino acids and characterize the function of these 
interactions. 
1.1.1 Mutagenesis Strategies to Generate Protein Variants 
Site-directed mutagenesis (SDM) is a fundamental approach to study the contribution of 
single amino acid side chains to the properties of proteins. Alanine-scanning mutagenesis 
has been successfully used to assess protein structure function relationships and 
systematically map functional binding sites (Ashkenazi et al., 1990; Cunningham and Wells, 
1989; Matthews, 1996). Many commercially available site-directed mutagenesis kits offer fast 
protocols that are based on PCR-primers harboring the mutation (Hogrefe et al., 2002; Zhu et 
al., 2007). However, those strategies contain one or more disadvantages: First, they either lack 
a marker to select mutant clones (Invitrogen, Genetailor SDM system), or, if it is included, the 
procedure gets more time-consuming: Either prior transfer to a special vector or two rounds 
of transformation in different E.coli strains are necessary (Clontech, Transformer SDM Kit; 
(Andrews and Lesley, 1998; Deng and Nickoloff, 1992). Second, mutations are placed in 
oligonucleotide primers and the complete vector DNA has to be amplified risking the 
acquisition of additional unwanted mutations. In some cases the template DNA has to be 
eliminated by an additional digestion step, e.g. with DpnI (Stratagene, QuikChange SDM kit; 
Clontech, Transformer SDM kit). Third, the creation of single point mutants, deletions and 
insertions is not only limited to a certain number of bases but also the size of the target 
vector is restricted to 8-10 kb for high efficiency of the protocols (Invitrogen, Genetailor SDM 
system; NEB, Phusion SDM kit). Therefore, we developed a fast and robust alanine-scanning 
mutagenesis strategy that is not restricted by the limitations mentioned above and most 
importantly allows simultaneous generation of a large set of substitution, deletion and 
insertion mutants (see Results 2.1). 
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1.1.2 Methods to Study Protein-Protein Interactions 
Various methods focusing on different aspects are available to study protein-protein 
interactions and protein complexes. Major methods comprising different advantages and 
disadvantages are described in the following chapter. 
Table 1.1 Schematic overview of methods to study protein-protein interactions that are described in the following 
chapter in detail. 
Method Major Advantage Major Disadvantage 
Large Scale Screens for the Identification of Protein-Protein Interactions 
Yeast Two-Hybrid cheap high error rate 
Mass-Spectrometry identify protein complex 
composition 
expensive 
Protein Chip high throughput screen results limited by 
experimental conditions 
Small Scale Assays for the Analysis of Protein-Protein Interactions 
Fluorescence Based Protein-Protein Interaction Methods 
Fluorescence Resonance Energy 
Transfer 
in vivo and in vitro technically demanding 
Bimolecular Fluorescence 
Complementation 
in vivo irreversible fluorophore 
assembly 
Fluorescence Two-Hybrid in vivo, simple to use requires cell line with lac 
operator array 
Biochemical Methods 
Analytical Ultracentrifugation complex characterization 
possible 
requires pure protein 
fractions 
Surface Plasmon Resonance sensitive measurements 
possible 
expensive 
Affinity Purification detects direct interactions might miss posttranslational 
modifications 
GFP-Nanotrap fast, quantitative 
pulldown 
“large” GFP-tag necessary 
 
1.1.2.1 Large Scale Screens for the Identification of Protein-Protein Interactions 
Genetic Yeast Two-Hybrid Screen 
A classical genetic method to identify interacting proteins is the yeast two-hybrid screen 
(Y2H, (Fields and Song, 1989)). This method is based on two functional domains of a yeast 
transcription factor (e.g. GAL4): First, a DNA binding domain directs the transcription factor to 
an upstream activator sequence (UAS) of a transcriptional unit and second, an activator 
domain initiates transcription by recruiting the RNA polymerase II complex. For a Y2H 
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interaction screen, the protein of interest is fused to the DNA-binding domain that targets 
the protein to the UAS sequence of a reporter gene and serves as bait. Potentially interacting 
candidate proteins taken from a cDNA library are fused to the transcriptional activator 
domain and serve as prey. Only if the bait and prey proteins interact, the DNA binding 
domain and the activator domain form a complex, reconstitute the transcription factor and 
switch on the reporter gene. Commonly used reporter genes are leucine (Leu2) or histidine 
(HIS3) that allow screening with auxothrophic media. Another marker is LacZ, a 
ß-galactosidase that catalyzes the conversion of X-Gal to 5’5-dibrom-4,4’-dichlorindigo 
leading to a blue coloration of the yeast cells (Durfee et al., 1993; Fields and Song, 1989; 
Vojtek et al., 1993). In summary, the interaction of two proteins can be detected by the 
reconstitution of a transcription factor that initiates the expression of reporter genes. Y2H 
screens have been successfully applied to identify protein-protein interactions in large-scale 
studies (Boxem et al., 2008; Vidal, 2005). However, they also have some disadvantages. A high 
rate (up to 50%) of the results is false-positive or false-negative (Deane et al., 2002). Besides, 
prior to screening self-activation of the bait fusion protein has to be excluded. In addition, 
yeast cells cannot spatially or dynamically resolve protein-protein interactions that take place 
in distinct cell compartments in higher eukaryotic cells. Furthermore, not only the limited 
chaperone diversity in yeast might affect proper folding of mammalian proteins but also 
posttranslational modifications that could be crucial for certain interactions might be absent. 
The standard Y2H has been modified to achieve a better reliability (Vidal and Legrain, 1999). 
For further functional analyses, identification of mutations that specifically disrupt the 
interaction is important. For this purpose, modified yeast two-hybrid systems such as reverse 
two-hybrid screens have been developed (Jin et al., 2007; Vidal et al., 1996a; Vidal et al., 
1996b). In any case, interactions initially identified by Y2H should be confirmed in an 
independent protein-protein interaction assay such as affinity-purification. Bacterial two-
hybrid screens (B2H) can be carried out analogously to Y2H. B2H allows interaction screens of 
large libraries (<108) due to higher transformation efficiency and faster expansion of E.coli 
(Hu et al., 2000; Joung et al., 2000). 
Mass-Spectrometry 
Mass-spectrometry is an important tool for analyzing and characterizing biological samples 
of varying complexity. The technology allows getting insights into the composition, 
regulation and function of molecular complexes and pathways (Aebersold and Mann, 2003; 
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Ong and Mann, 2005). To analyze protein complexes, the protein of interest is used as bait 
for affinity purification to isolate interacting proteins. If specific antibodies are available, the 
endogenous protein can be immunoprecipitated and protein over-expression that might 
result in non-physiological levels and subsequent artifacts is not necessary. A multitude of 
mass spectrometers with different characteristics are available (reviewed in (Domon and 
Aebersold, 2006)). In general, after affinity purification of a protein complex, samples are 
separated by SDS-PAGE, protein bands are excised, digested by trypsin and the peptide 
mixture is separated by high-pressure liquid chromatography in very fine capillaries. 
Subsequently, the peptides are eluted to an ion source (e.g. electrospray ionization (ESI)) 
where they get incorporated into small highly charged droplets. After evaporation, the mass 
spectrometer records a mass spectrum of the peptides (according to their mass-to-charge 
ratios). Tandem (MS/MS) mass spectrometers have more than one analyzer and allow 
structural and sequencing studies. A MS/MS spectrum is recorded after peptide 
fragmentation and matched against the protein sequence database. Data analysis reveals the 
identity of the peptides, the proteins and hence the composition of the initially isolated 
protein complex. One major advantage of this technology is that the bait protein can be 
isolated from its native environment, i.e. fully processed and modified in living cells. However, 
proteins identified in one complex reflect only a fraction of the occurring protein-protein 
interactions, as low affinity or transient interactions can be lost during the affinity purification 
of the protein complex. In summary, mass spectrometry provides high-content, quantitative 
information about highly complex biological samples. 
Protein Chip 
Protein chips allow the identification and quantification of protein-protein interactions in 
large scale. The major advantages of protein chips are highly sensitive measurements and the 
possibility to analyze a large number of parameters in one experiment (Kung and Snyder, 
2006; Templin et al., 2003). To setup a protein chip, antibodies, proteins or cell lysates are 
spotted on a surface and serve as bait. After incubation of the chip with a prey protein 
mixture, bound proteins are detected either by radioactivity, fluorescently or 
chemiluminescently labeled antibodies. The high sensitivity of protein chips is due to building 
of a protein complex at maximal concentration of the bait protein. In addition, bait-prey 
protein complexes are formed at a small, defined spot resulting in high local signal intensity 
(Ekins and Chu, 1992). However, proteins vary significantly in terms of solubility, charge and 
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stability. Moreover, protein-protein interactions are dependent on buffer conditions as pH, 
salt concentrations and cofactors. Thus, as a global protein-protein interaction chip cannot 
meet the requirements of all different kinds of proteins, the results have to be evaluated 
under consideration of the experimental conditions. Nonetheless, protein chips are an 
important tool for high throughput analysis of protein-protein interactions (Jones et al., 2006; 
MacBeath and Schreiber, 2000). 
1.1.2.2 Small Scale Assays for the Analysis of Protein-Protein Interactions 
Fluorescence Based Protein-Protein Interaction Methods 
The fusion of fluorophores to proteins allows the analysis of protein distribution, dynamics 
and interactions in their natural environment – in living cells (Phair and Misteli, 2001). Further 
modeling of kinetic data provides insights into biophysical properties of molecules. However, 
over-expression of fluorescent fusion proteins is artificial and therefore correct localization 
should be controlled first. This can be done by comparing the distribution of the fusion 
protein with antibody stainings of the endogenous protein. 
Fluorescence Resonance Energy Transfer 
Fluorescence resonance energy transfer (FRET), discovered 1946 by Theodor Förster is a 
physical process where energy of an excited donor fluorophore is transferred without 
emission of a photon to an acceptor fluorophore. This effect can be observed in vitro and in 
vivo. Importantly, the donor fluorophore must have an emission spectrum overlapping with 
the excitation spectrum of the acceptor fluorophore. A well suited donor-acceptor pair is the 
cyan fluorescent protein (CFP) and the yellow fluorescent protein (YFP). Only if the two 
fluorophores are in close proximity (1-10 nm), energy can be transferred and excite the 
acceptor fluorophore. To analyze protein-protein interactions, two candidate proteins are 
fused to CFP and YFP respectively and expressed in cells. Upon interaction of the two 
proteins, FRET between CFP and YFP can be measured and the donor fluorescence is 
quenched while the acceptor fluorescence signal increases (Periasamy, 2001). Signal intensity 
of FRET is dependent on the distance between the two fluorophores. Therefore, N- or C-
terminal fusions of the fluorophores can result in a protein complex where the distance 
between them is too large to detect FRET. In addition, depending on the orientation, a 
fluorescent fusion can prevent an interaction that could occur between endogenous proteins. 
Hence, a set of controls is needed to avoid false-negative results. Recently, photobleaching of 
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YFP was reported to lead to photoconversion of the protein and to produce a byproduct with 
CFP-like fluorescence (Kirber et al., 2007; Valentin et al., 2005). For this reason this classic 
FRET pair needs additional controls for the use in protein-protein interaction studies or newly 
developed FRET pairs should be considered (Ai et al., 2008). 
Bimolecular Fluorescence Complementation 
Bimolecular fluorescence complementation (BiFC) is also used to analyze protein-protein 
interactions in vivo. This method is based on the reconstitution of a fluorophore such as the 
green fluorescent protein GFP (Magliery et al., 2005) or the monomeric red fluorescent 
protein mRFP1 (Jach et al., 2006). Two nonfluorescent halves of a fluorescent protein are 
fused to two candidate proteins. If the candidate proteins interact, the fluorophore is 
reconstituted by assembly of the two parts and the fluorescent signal can be observed (Hu et 
al., 2002). However, the association of the fluorescent protein fragments is irreversible 
(Kerppola, 2006) and fluorescent protein fragments have a natural capability to interact 
independent of fused proteins. In addition, chemical reactions of fluorophore reconstitution 
are too slow to be monitored in real time. Therefore, bimolecular fluorescence 
complementation is a technically demanding assay that if applied with the appropriate 
controls can be a versatile method to monitor protein-protein interactions. 
Fluorescence Two-Hybrid 
The fluorescence two-hybrid assay (F2H) allows direct visualization of protein-protein 
interactions in single living cells (Zolghadr et al., 2008). The F2H assay monitors the 
interaction of e.g. a red fluorescent bait with a green fluorescent prey protein as co-
localization at a defined nuclear spot. To anchor the fluorescent bait, transgenic cells that 
contain a chromosomally integrated lac operator array are used and provide a defined 
binding platform for Lac repressor fusion proteins. The protein of interest (X) is fused to the 
Lac repressor and a fluorescent protein (e.g. mRFP) and serves as bait. Binding of the triple 
fusion protein (X-LacI-RFP) to the lac operator array can directly be visualized by fluorescence 
microscopy as nuclear spot in living cells. Interaction of green fluorescent prey proteins with 
red fluorescent protein X leads to co-localization at the anchor point and is visible in an 
overlay image as orange/yellow spot. To exclude false positive or false negative results 
appropriate controls have to be performed. In summary, the F2H assay provides a simple 
optical read-out to visualize protein-protein interactions. If a cDNA library is cloned into the 
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bait vector (cDNA-LacI-RFP), large-scale screenings of protein-protein interactions can be 
performed in 96 well formats by high throughput microscopy and automated image analysis. 
Biochemical Methods 
Biochemical methods are often used to validate and characterize protein-protein interactions 
that were initially identified by large scale screens as with the methods described above. 
Analytical Ultracentrifugation 
Analytical ultracentrifugation is used to determine the molecular weight, hydrodynamic and 
thermodynamic properties of a protein or macromolecule and even short-lived complexes 
can be detected. Sedimentation and diffusion coefficients and ligand binding can all be 
analyzed using this versatile instrument. An analytical ultracentrifuge provides sample 
rotation at a controlled speed (up to 250,000 g) and temperature under vacuum and 
periodically records the spatial distribution of protein concentration. The protein sample is 
placed in a cell that contains two windows of quartz or sapphire to allow measurements at 
different radial positions and at different times. The data obtained from sedimentation 
velocity experiments is a record of the concentration distribution including the sedimentation 
constant, the diffusion and friction co-efficient. In sedimentation-equilibrium experiments the 
density of the protein complex is determined (Lebowitz et al., 2002). Sucrose gradient 
experiments lead to accumulation of the protein fraction at a point in the sucrose gradient 
where its density matches with the surrounding sucrose and allows purification and further 
analysis of the protein complex fraction. 
Surface Plasmon Resonance 
Surface plasmon resonance (SPR) spectroscopy allows the determination of binding 
constants, enzyme-substrate interactions, DNA/RNA-protein interactions and others. SPR 
instruments such as Biacore measure the refractive index near a sensor surface (300 nm), that 
represents the basis of a flow cell through which an aqueous solution passes in continuous 
flow. The SPR field is very sensitive to any change such as the adsorption and dissociation of 
molecules. To analyze (protein) interactions a ligand is immobilized on the sensor surface and 
the analyte is injected in the same aqueous solution under constant flow into the flow cell. 
Binding of the analyte to the immobilized ligand leads to a change in the refractive index that 
is measured in real time. Hence, time constants as well as equilibrium constants can be 
calculated. Measurements have to be performed under constant optical conditions, in the 
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same buffer system to accurately detect binding of molecules. SPR offers several advantages: 
High sensitivity, time resolution, specificity and label-free detection but it is cost-intensive 
(Anker et al., 2008; Phillips and Cheng, 2007). 
Affinity Purification 
Affinity purification allows the enrichment and purification of interacting proteins. After 
immobilization of one ligand to a matrix, a complex mixture of proteins can be loaded and 
only the interacting protein is specifically bound. Pull-down assays are one kind of affinity 
purification to test physical interaction between proteins in vitro. The glutathione-S-
transferase (GST) pulldown is commonly used and well suited to either perform an initial 
interaction screening or to confirm predicted protein-protein interactions. A protein of 
interest is fused to GST (bait), expressed in E.coli and purified using sepharose beads coated 
with glutathione. The immobilized bait protein is then incubated with a prey protein that can 
be either a purified protein or part of a whole cell lysate. After several washing steps bound 
proteins are eluted by denaturing sample buffer or glutathione and proteins are separated 
according to their molecular mass by SDS polyacrylamide electrophoresis (PAGE). Interacting 
proteins can be visualized by coomassie staining or after protein transfer to a membrane by 
specific antibodies (immunoblotting). For (co-)immunoprecipitation assays, antibodies are 
coupled to beads and specifically enrich native antigen-complexes from a cell lysate. New 
interaction partners can be identified by mass spectrometry and immunoblotting. To 
distinguish between direct or indirect interactions purified proteins have to be used. 
Nonetheless, to analyze protein-protein interactions biochemical methods are important 
accepted standard techniques (Cho et al., 2004). 
GFP-Nanotrap 
In our group, we also use a modified co-immunoprecipitation approach to detect and map 
protein-protein interactions. It is based on an antibody fragment of a single-chain antibody 
of camelidae. Camelids have not only conventional antibodies but also single chain 
antibodies that are composed exclusively of single truncated H-chains (Hamers-Casterman et 
al., 1993). The smallest antigen-binding fragment consists of the heavy chain variable domain 
(VHH), has a molecular size of 15 kDa and binds to its antigen with nanomolar affinity 
(Muyldermans et al., 1994; Muyldermans and Lauwereys, 1999; Muyldermans and Travers, 
1994). We use a GFP-binding antibody fragment (GBP; GFP-Nanotrap) that was developed in 
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our group for biochemical interaction studies (Rothbauer et al., 2008). GFP is fused to a 
protein of interest, the fusion protein is expressed and enriched with the GFP Nanotrap from 
a crude cell extract. Interacting proteins are further analyzed by immunoblotting. Compared 
to a classical co-immunoprecipitation approach using conventional antibodies, the GFP-
Nanotrap offers several advantages: First, the small GBP (13 kDa) is coupled covalently 
through a NHS ester bond to agarose beads providing a binding platform for GFP. Second, 
incubation of one to two hours is enough to quantitatively enrich a GFP fusion protein from a 
cell lysate. Third, we do not have any disturbing signals of antibody light and heavy chains on 
coomassie stained PAGE gels or immunoblots as the GBP fragment is covalently coupled by a 
NHS-ester bond to sepharose beads. In summary, the GFP Nanotrap provides a versatile and 
time efficient co-immunoprecipitation assay to study protein-protein interactions. A further 
advantage of this system is that one and the same GFP fusion protein can be analyzed both 
by biochemical methods and by fluorescence microscopy to study localization, dynamics and 
interactions in living cells. 
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1.2 Establishment and Maintenance of DNA Methylation 
DNA methylation is established and maintained by the family of DNA methyltransferases 
(Dnmts). These enzymes transfer methyl groups from S-adenosyl-L-methionine (SAM) to 
cytosines (at carbon 5) in the context of CpG sites (Wu and Santi, 1987). CpG methylation 
occurs in all vertebrates, flowering plants, some fungal, invertebrate and protist taxa and 
many bacteria. In bacteria, DNA methylation is part of the restriction modification system that 
protects the host genome against foreign DNA such as bacteriophages (Wilson and Murray, 
1991). In vertebrates, it has a repressive effect on gene expression. DNA methylation patterns 
are reprogrammed by waves of demethylation and remethylation during early mammalian 
embryogenesis. During pre-implantation development, maternal and paternal methylation 
patterns are erased except for imprinted loci and retroviral elements (e.g. intracisternal A-
type particles, IAPs). After implantation, methylation patterns are established through 
lineage-specific de novo methylation by Dnmt3a and 3b and maintained in somatic cells by 
Dnmt1 (Howlett and Reik, 1991; Li, 2002; Santos et al., 2002). 
 
Figure 1.1 Schematic overview of the mammalian DNA methyltransferase family. Subdomains are indicated: PBD, PCNA 
binding domain; TS, targeting sequence; ZnF, CXXC-type zinc finger; BAH1+2, bromo adjacent homology domain 1+2; I-
X, catalytic methyltransferase motifs; PWWP, domain with conserved pro-trp-trp-pro motif; PHD, plant homeo domain. 
The family of DNA methyltransferases comprises five members (Figure 1.1). Dnmt1 is the 
maintenance methyltransferase, it associates with replication sites and copies methylation 
patterns from the parental to the newly synthesized daughter DNA strand (Chuang et al., 
1997; Leonhardt et al., 1992). Dnmt2 was described as RNA methyltransferase for tRNAAsp 
(Goll et al., 2006) and shown to act through a DNA methyltransferase-like catalytic 
mechanism (Jurkowski et al., 2008). Dnmt3a and 3b are de novo DNA methyltransferases that 
are responsible for the establishment of methylation patterns early in development (Okano et 
al., 1998). Although Dnmt3L lacks crucial methyltransferase motifs and is not catalytically 
active, it plays an essential role in the regulation of Dnmt3a and 3b (Aapola et al., 2002; Hata 
et al., 2002; Jia et al., 2007; Suetake et al., 2004). 
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1.2.1 Maintenance DNA Methyltransferase 1 
Dnmt1 is ubiquitously expressed and responsible for the inheritance of DNA methylation 
patterns. Homozygous knockout of the dnmt1 gene in mice leads to genome-wide loss of 
DNA methylation and embryonic lethality (Lei et al., 1996; Li et al., 1992). Reduction of cellular 
Dnmt1 levels severely affects development and genome stability (Gaudet et al., 2003; Gaudet 
et al., 2004). Dnmt1 consists of two major domains: A regulatory N-terminal domain that is 
unique among the family of DNA methyltransferases and a C-terminal catalytic domain. The 
two parts of the enzyme are linked via a glycine-lysine linker (GK)7. The large N-terminal 
domain of Dnmt1 contains several subdomains: The PCNA binding domain (PBD, (aa) 159-
178) targets Dnmt1 to the replication machinery during S phase where it associates with the 
loading platform PCNA. It was described recently, that this interaction enhances methylation 
efficiency by twofold but is not strictly required for methylation maintenance (Chuang et al., 
1997; Schermelleh et al., 2007; Spada et al., 2007). The N-terminal targeting sequence (TS, aa 
310-629) recruits Dnmt1 to heterochromatin in a process that is independent of replication, 
the presence of H3K9 trimethylation, the interacting histone methyltransferase SUV39H1 and 
HP1 (Easwaran et al., 2004; Leonhardt et al., 1992). Besides, the TS contains a zinc finger motif 
(Bestor, 1992; Chuang et al., 1996). The prominent N-terminal CXXC zinc-finger (ZnF, aa 648-
694) of Dnmt1 was described to be essential for allosteric activation of the catalytic domain 
of Dnmt1 (Fatemi et al., 2001). The structure of a very similar zinc-finger from the mixed-
lineage leukemia protein (MLL) was solved by nuclear magnetic resonance spectroscopy 
(NMR) (Allen et al., 2006). Both, the MLL zinc finger and the homolog zinc-finger of the CpG 
binding protein (CGBP) bind to unmethylated CpG DNA (Birke et al., 2002; Lee et al., 2001). 
The respective zinc motif of MBD1 was shown to bind both methylated and unmethylated 
CpG sites (Jorgensen et al., 2004). In addition, the Dnmt1 N-terminus comprises two bromo 
adjacent homology domains (BAH1+2; aa 758-884 and 935-1103) whose functions are still 
unknown (Liu et al., 1998). BAH domains have also been found in other proteins where they 
are involved in protein-protein interactions specialized in gene silencing as in the yeast Orc1p 
– Sir1p (origin recognition complex 1 – silent information regulator 1) interaction (Callebaut 
et al., 1999). At least three nuclear localization signals (NLS) have been identified in the 
Dnmt1 N-terminus (Leonhardt and Cardoso, 2000). In contrast to the unique regulatory N-
terminal domain of Dnmt1, the catalytic domain is very well conserved among DNA 
methyltransferases. Even though it contains all typical conserved methyltransferase motifs 
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necessary for catalysis, the catalytic domain of Dnmt1 per se lacks catalytic activity. Thus, the 
intramolecular interaction between the regulatory N-terminus and the catalytic C-terminus is 
essential for the catalytic activity of Dnmt1 (Fatemi et al., 2001; Margot et al., 2000; Margot et 
al., 2003). In addition, Dnmt1 is the only methyltransferase with a preference for hemi-
methylated CpG sites (Stein et al., 1982) that assures correct transmission of cytosine 
methylation not only during DNA replication but also during DNA repair (Mortusewicz et al., 
2005). It is still unknown, how the activity and specificity of Dnmt1 are regulated. To address 
these questions we performed detailed analyses of Dnmt1: We mapped subdomains of the 
regulatory N-terminus that are indispensible for N-C terminal interaction and therefore 
catalysis to receive a minimal active Dnmt1 enzyme (Results, 2.2). DNA methyltransferases 
seem to have no sequence specificity beyond CpG recognition (Dodge et al., 2002; Okano et 
al., 1998; Yoder et al., 1997). Interactions with chromatin factors may direct Dnmts to target 
sites or help Dnmts to access target cytosines (Bird, 2002). 
 
  
The goal of this work was to identify subdomains of Dnmt1 and interacting 
proteins that contribute to functional specialization of the enzyme. 
Interaction of Dnmt1 with the chromatin factors Np95, LSH and EZH2 was 
shown to be essential for maintenance of DNA methylation (Bostick et al., 
2007; Myant and Stancheva, 2008; Sharif et al., 2007; Vire et al., 2006). 
However, the molecular mechanisms of these multiple interactions 
controlling the activity of Dnmt1 and the recognition of hemi-methylated 
target sites are still largely unknown. To understand this epigenetic protein 
network involved in the regulation of DNA methylation we studied Dnmt 
domains to identify interaction partners; we further mapped and mutated 
the interacting domains to study their function. 
Introduction 
 
 
16   
1.2.2 De novo DNA Methyltransferases 3a and 3b 
Dnmt3a and 3b establish DNA methylation patterns de novo in early development. They are 
highly expressed in ES cells, early embryos and developing germ cells and are downregulated 
after differentiation in somatic cells (Okano et al., 1998). Dnmt3a and Dnmt3L are essential 
for the establishment of methylation imprints during gametogenesis (Bourc’his 2001, Hata 
2002, Kaneda 2004). Targeted disruption of both, dnmt3a and dnmt3b genes inhibits de novo 
methylation in ES cells and early embryos. dnmt3a-/- mice are runted but survive until 
adulthood. Global methylation levels seem to be normal (Okano et al., 1999), however studies 
of a conditional knockout of dnmt3a in germ cells reported that Dnmt3a is required in male 
germ cells for the methylation of differentially methylated regions (DMRs) of imprinted genes 
like H19 and Gtl2-Dlk1 (Kaneda et al., 2004). dnmt3b-/- mice die at 9.5 days post coitum 
exhibiting loss of methylation at minor satellite repeats. In humans, point mutations in 
DNMT3b cause a rare autosomal recessive disorder called the ICF (immunodeficiency, 
centromere instability and facial anomalies) syndrome (Xu et al., 1999). Methylation of 
pericentromeric regions of chromosomes 1, 9 and 16 is missing, leading to chromosomal 
instability. Altogether, these studies demonstrate that correct function of Dnmt3a and 3b is 
vital for normal development. In addition to their function as de novo methyltransferases, 
Dnmt3a and 3b play also a role in the maintenance of methylation patterns. Inactivation of 
dnmt3a and dnmt3b in ES cells by targeted disruption leads to a progressive decrease of 
global DNA methylation levels (Chen et al., 2003; Liang et al., 2002), although Dnmt3a and 3b 
show no preference for un- or hemimethylated CpG sites in vitro (Aoki et al., 2001; Okano et 
al., 1998). Dnmt3a and 3b differ only in their regulatory N-terminal domains, while their 
catalytic domains are highly homologous. The N-terminal variable region contains 280 amino 
acids for Dnmt3a and 220 amino acids for Dnmt3b. Both contain an N-terminal PWWP 
domain named after the characteristic pro-trp-trp-pro motif (Dnmt3a aa 289-246, Dnmt3b aa 
228-363 (Qiu et al., 2002; Stec et al., 2000)). The PWWP domain was described to be 
responsible for targeting Dnmt3a and 3b to pericentric heterochromatin (Chen et al., 2004; 
Ge et al., 2004). Moreover, Dnmt3a and 3b comprise an ATRX homology domain that 
includes a C2-C2 zinc finger and a PHD-like domain (plant homeo domain (Okano et al., 
1998; Xie et al., 1999)). This domain has been described to interact with various chromatin 
proteins like histone deacetylases (HDACs), heterochromatin protein 1 (HP1) and the histone 
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methyltransferase suppressor of variegation 3-9 homolog 1 (SUV39H1) (Fuks et al., 2001). 
Still, the regulation of Dnmt3a and 3b remains largely unknown.  
 
  
In this work, we identified Np95 as one common regulatory factor for 
Dnmt1, 3a, 3b and characterized its interactions and role in gene silencing. 
(see Results 2.4, 2.5) 
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1.3 The Epigenetic Protein Network 
A multitude of epigenetic proteins is responsible for large chromatin diversity including DNA 
methylation marks and histone modifications such as methylation, acetylation, 
phosphorylation, ribosylation, ubiquinylation and others (Kouzarides et al., 2007). Positively 
charged histone tails are target for modifications and preferentially lysines and arginines are 
subjected to mono-, di-, tri-methylation or acetylation. Different modifications and 
combinations of modifications lead to complex packaging mechanisms and a differential 
accessibility of the DNA e.g. for transcription factors. Moreover, in such a crowded 
environment chromatin remodeling factors play a fundamental role to provide chromatin 
flexibility and access to DNA (Becker and Horz, 2002; Varga-Weisz and Becker, 2006). This 
work is focused on DNA methyltransferases – the other hall mark of epigenetic modifications 
besides histone modifiations. Thus, in the following interactions among DNA 
methyltransferase enzymes and the interface between DNA methylation and histone 
modifications will be elucidated and the role in development, disease and reprogramming 
will be discussed. 
1.3.1 Interactions within the Mammalian DNA Methyltransferase Family 
Several DNA methyltransferases participate in the establishment and maintenance of DNA 
methylation patterns (Figure 1.2). Cooperation of de novo and maintenance 
methyltransferases ensures proper methylation patterns while deficiency of one or more 
methyltransferases results in hypomethylation. 
 
Figure 1.2 Interactions within the Dnmt family. Grey lines indicate interactions. Dnmt1 interacts with Dnmt3a and 3b 
and the Dnmt1 N-terminal domain allosterically activates the C-terminal domain. Dnmt3a and Dnmt3L can form dimers 
and together a Dnmt3L-3a-3a-3L tetramer. Dnmt3a and 3b interact with each other and with Dnmt3L. 
Dnmt1 interacts with both, Dnmt3a and Dnmt3b (Kim et al., 2002). These interactions are 
mediated by the N-terminal regulatory domains of Dnmt1 and Dnmt3a/b. Dnmt3a and 
Dnmt3b function synergistically in the methylation of Oct4 and Nanog in embryonic stem 
cells and mouse postimplantation embryos through direct interaction (Li et al., 2007). Dnmt3L 
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stimulates the catalytic activity of both, Dnmt3a and Dnmt3b, by interacting with their 
catalytic domains (Chedin et al., 2002; Gowher et al., 2005; Kareta et al., 2006; Suetake et al., 
2004). Expression of Dnmt3L was reported to be controlled by Dnmt3L promoter methylation 
during embryonic development (Hu et al., 2008). Mechanistic insights provided the crystal 
structure of a Dnmt3L-3a-3a-3L tetramer (Jia et al., 2007). The crystal structure of the C-
terminal domains revealed that the Dnmt3L-Dnmt3a interface stabilizes the conformation of 
the active site loop of Dnmt3a and hence suggested a model for de novo methylation of 
imprinted genes. Mutation of either the Dnmt3a-Dnmt3a or the Dnmt3a-Dnmt3L interface 
disrupted catalytic activity. The central Dnmt3a dimer in the tetramer methylated two CpG 
dinucleotides that are 8-10 bp apart in one binding event and this spacing was preferentially 
found in imprinting control regions. In addition, a whole human genome search revealed a 
high over-representation of CpG dinucleotides with an 8-10 base pair periodicity, indicating 
potential target sites for 3a-3L tetramers throughout the genome (Ferguson-Smith and 
Greally, 2007). Interestingly, the Dnmt3a homolog in plants DRM2 (domains rearranged 
methylase 2) methylates DNA genome-wide with a comparable periodicity (Cokus et al., 
2008). Moreover, Dnmt3a-3L complexes were shown to multimerize on DNA, forming 
protein-DNA filaments. CpG methylation in a distance of 8-10 bp on opposite DNA strands 
was observed by in vitro studies, correlating with the geometry and distance of the two active 
sites in one Dnmt3a-3L tetramer (Jurkowska et al., 2008).  
 
  
These interdependencies indicate that DNA methylation is coordinated by a 
complex interplay between the members of the DNA methyltransferase 
family. Moreover, the molecular mechanisms of the regulation of Dnmts by 
interacting chromatin factors such as histone modifying enzymes are not yet 
understood in detail. 
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1.3.2 Interface between DNA Methyltransferases and Histone Modifying Enzymes 
DNA methyltransferases interact with various histone modifying enzymes but so far, only one 
DNA methyltransferase was described to interact directly with a histone modification. Dnmt3L 
binds to unmethylated lysine 4 of histone H3 (H3K4) through its N-terminal PHD domain, 
thereby Dnmt3a is recruited or activated to induce de novo methylation (Ooi et al., 2007). The 
crystal structure of Dnmt3L revealed C-terminal to the PHD domain a classical 
methyltransferase fold. The co-crystal structure of the Dnmt3L and the H3 tail showed a 
specific binding of unmethylated but not methylated H3K4. Dnmt3L seems to respond to 
states of histone modification to regulate de novo DNA methylation. 
In addition to the interactions within the DNA methyltransferase family, numerous other 
interacting chromatin factors are involved in the regulation of DNA methylation. To illustrate 
this complexity the cellular factors reported to interact with Dnmt1 are outlined in Figure 1.3. 
 
Figure 1.3 Reported interacting factors of Dnmt1: Dnmt3a and Dnmt3b (Kim et al., 2002); Np95 (Bostick et al., 2007; 
Sharif et al., 2007); hSNF2H / Tip5 (Zhou and Grummt, 2005); LSH (Myant and Stancheva, 2008); EZH2 (Vire et al., 2006); 
HP1β (Fuks et al., 2003); MeCP2 (Kimura and Shiota, 2003); MBD2 / MBD3 (Tatematsu et al., 2000); pRb / E2F1 
(Robertson et al., 2000); DMAP1 (Rountree et al., 2000); RGS6 (Liu and Fisher, 2004); PML-RAR (Di Croce et al., 2002); 
P23 (Zhang and Verdine, 1996); Annexin V (Ohsawa et al., 1996); PARP-1 (Reale et al., 2005); Hsp90 (Zhou et al., 2008); 
RIP140 (Kiskinis et al., 2007); PCNA (Chuang et al., 1997); CFP1 (Butler et al., 2008); SUV39H1 (Fuks et al., 2003); G9a 
(Esteve et al., 2006); HDAC1/2 (Robertson et al., 2000; Rountree et al., 2000). 
These interactions of Dnmt1 represent only a small section of this rather complex epigenetic 
protein network. The underlying molecular mechanisms and their interplay in the genome-
wide epigenetic regulation of gene expression is subject of intense research. Histone 
deacetylation correlates with transcriptional repression and the responsible histone 
deacetylase enzymes can also recruit Dnmts to establish DNA methylation marks. HDAC1 
interacts with Dnmt1, 3a, 3b and 3L while HDAC2 interacts only with Dnmt1 and 3b (Bachman 
et al., 2001; Deplus et al., 2002; Fuks et al., 2001; Geiman et al., 2004; Robertson et al., 2000; 
Rountree et al., 2000). The histone methyltransferase SUV39H1 binds HDAC1 and HDAC2 and 
is responsible for trimethylation of lysine 9 at histone H3 (H3K9) in heterochromatic regions. 
Moreover, SUV39H1 interacts with Dnmt1, 3a and 3b. SUV39H1 or the resulting H3K9 
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trimethylation can further recruit HP1 which also binds Dnmts (Fuks et al., 2003; Geiman et al., 
2004; Lehnertz et al., 2003). HP1α and HP1β are found only at heterochromatin while HP1γ is 
found at hetero- and euchromatin (Minc et al., 2000). G9a is also a H3K9 methyltransferase 
but acts on euchromatic DNA. G9a associates with Dnmt1, 3a and 3b (Epsztejn-Litman et al., 
2008; Esteve et al., 2006). A recent report suggests that the noncoding RNA Air recruits G9a 
to chromatin (Nagano et al., 2008). SETDB1 (suppressor of variegation, enhancer of zest and 
trithorax domain bifurcated 1) is another H3K9 methyltransferase that specifically 
trimethylates H3K9 and interacts with HDAC1 and 2 (Schultz et al., 2002; Yang et al., 2003; 
Yang et al., 2002). It mainly functions in euchromatic regions and plays a central role in the 
silencing of euchromatic promotors. SETDB1 interacts with de novo methyltransferases 
Dnmt3a and 3b but not with Dnmt1 (Li et al., 2006). LSH is a member of the SNF2H 
chromatin remodeling family and was shown to be essential for both types of epigenetic 
information – DNA methylation and histone tail methylation (De La Fuente et al., 2006; 
Dennis et al., 2001; Huang et al., 2004; Myant and Stancheva, 2008). LSH serves as a recruiting 
factor for Dnmts and HDACs to establish transcriptionally repressive chromatin that might be 
further stabilized by DNA methylation at targeted loci (Myant & Stancheva, 2008). Methyl 
CpG binding domain (MBD) proteins such as MeCP2, MBD1 and MBD2 bind to 5-methyl 
cytosine residues in CpG dinucleotides and are involved in transcriptional silencing. MeCP2, 
MBD2 and MBD3 interact with Dnmt1 (Kimura and Shiota, 2003; Tatematsu et al., 2000). 
There are many more chromatin binding factors involved in gene silencing that are not 
mentioned here. In general, it is very likely that repressive factors are able to recruit each 
other. The exact order of events has not been resolved so far. The clustering of epigenetic 
factors and the establishment of repressive chromatin modifications lead to gene silencing. In 
addition, RNA directed DNA methylation was first described in plants and latest research 
revealed the existence of similar mechanisms in mammals (Aravin et al., 2008; Kanno et al., 
2008; Kuramochi-Miyagawa et al., 2008; Tam et al., 2008; Watanabe et al., 2008). 
1.3.3 Epigenetic Mechanisms in Gene Silencing – a Crucial Process in Development 
and Disease 
Epigenetic modifications control gene expression profiles and therefore play a fundamental 
role in development, disease and gene therapy. Early in development pluripotent stem cells 
have the potential to specialize in various different lineages. During the process of 
differentiation, expression of pluripotency genes is epigenetically silenced through DNA 
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methylation and repressive histone modifications. Depending on the developmental 
program, distinct sets of genes are activated and lead to functional specialization of a cell. 
During this process, epigenetic marks are changed and are stably maintained in differentiated 
somatic cells. While histone modifications are flexible and can be reversed to allow 
expression of a respective gene, silencing of transposons and imprinted genes is long-term 
and requires DNA methylation that has to be maintained. 
Various diseases are caused or accompanied by drastic changes in the epigenetic landscape. 
The best studied example involving both genetic and epigenetic alterations is cancer. In 
general, cancer cells exhibit global hypomethylation and local hypermethylation of promoter 
regions of tumor suppressor genes. It was shown that silencing can occur at early stages 
during tumorigenesis and mostly involved disruption or over-activation of key signal 
pathways (Feinberg and Tycko, 2004; Yamada et al., 2005). These issues were extensively 
studied in the human colon cancer cell line HCT116. Methylation of the sfrp genes, the 
antagonists of the Wnt pathway was found, causing over-activation of the Wnt-pathway and 
therefore increased proliferation and expansion of stem-cell populations (Taketo, 2004). 
Treatment of the cells with DNA demethylating agents or disruption of the DNA 
methyltransferase genes could reactivate epigenetically silenced genes. Re-expression of 
these growth control genes resulted in phenotypic changes, ranging from decreased 
proliferation to induction of apoptosis or senescence (Bachman et al., 2003; Herman et al., 
1998; Suzuki et al., 2004).  
 
  
Understanding the molecular mechanisms that initiate and maintain 
epigenetic gene silencing could help to develop strategies for epigenetic 
cancer therapies to reverse the silencing process and reactivate critical 
genes. 
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1.3.4 Epigenetic Reprogramming and Transgene Silencing 
Major epigenetic changes have to occur during the reprogramming of a differentiated 
somatic cell into a pluripotent stem cell-like state. Reprogramming of somatic cells to 
induced pluripotent stem cells (IPS) has been achieved after virus-mediated transduction of 
the four transcription factors Oct4, Sox2, Klf4 and c-myc and subsequent selection for 
activation of the Oct4 target gene Fbx15 (Takahashi and Yamanaka, 2006). Recently, the 
dispensability of the proto-oncogene c-myc for this transition was shown, but the process 
required more time and was less efficient (Nakagawa et al., 2008; Wernig et al., 2008; Yu et al., 
2007). Exogenous expression of the three or four factors leads to the activation of the 
endogenous counterparts that is further maintained by an autoregulatory loop by binding of 
the transcription factors to their promoters (Boyer et al., 2005). After selection of the IPS by 
activation of endogenous Oct4 or Nanog, the cells exhibited a pluripotent ES cell state by 
indistinguishable global gene expression, chromatin configuration and they generated 
postnatal chimeras and contributed to the germline (Maherali et al., 2007; Okita et al., 2007; 
Wernig et al., 2007). During the reprogramming process de novo methyltransferases Dnmt3a 
and Dnmt3b are activated and cause silencing of moloney virus vectors through methylation 
(Okano et al., 1999). It is important to understand the sequence of key events in the 
reprogramming process in order to be able to explore the potential of nuclear 
reprogramming as a source of patient-specific cells. In addition, the consequences of 
silencing and re-activation of viral vectors should be elucidated to enable the development of 
stable expressing vectors that are suitable for gene therapy. 
CpG islands are generally located in the promoter region of housekeeping genes, have a CG 
content of at least 55% and most importantly they are inherently resistant to de novo 
methylation (Bestor et al., 1992; Bird, 1986; Caiafa and Zampieri, 2005). CpG islands are 
protected from methylation to ensure gene expression. In addition, a CpG island fused to a 
provirus sequence had the capacity to confer transcriptional activity to the provirus (Hejnar et 
al., 2001). The shielding mechanism from methylation has not been elucidated so far, but it is 
damaged in cancer cells where methylation of CpG islands leads to gene silencing of tumor 
suppressor genes (Palii and Robertson, 2007). 
Transgene silencing is a common issue occurring in stable cell lines or transgenic mice 
(Mehta et al., 2009). The strong viral cytomegalie virus major immediate early (CMV) 
promoter is routinely used in expression vectors. Transgenic mice using CMV promoter 
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driven expression showed either reproducible expression patterns in different tissues or 
silencing of the transgene a few weeks after gene transfer (Fitzsimons et al., 2002; Schmidt et 
al., 1990; Villuendas et al., 2001). In vivo silencing of the CMV promoter has been associated 
with DNA methylation (Brooks et al., 2004), reduced histone tail acetylation (Murphy et al., 
2002) and could be reversed by treatment with inhibitors of DNA methylation and histone 
deacetylation (Choi et al., 2005; Grassi et al., 2003; Meier, 2001). In addition, depending on 
the integration in euchromatic or heterochromatic regions of the host genome, the CMV 
driven transgene was expressed or not, respectively (Mehta et al., 2009). 
Viral or bacterial promoter regions containing unmethylated CpG dinucleotides have an 
immunstimulatory effect and rapidly induce the innate immune system through toll-like 
receptor 9 (TLR9) (Sawamura et al., 2005). CpG methylation of the promoter regions of 
transgenes impedes stable, long lasting expression which would be required for successful 
gene therapy. To circumvent silencing through CpG DNA methylation CpG-free expression 
vectors have been generated, are commercially available and contain CpG-free versions of 
the mouse CMV enhancer and the human EF1 promoter to allow stable transgene expression 
(Invivogen, pCpG-vitro). Moreover, a mouse model was described were the use of a CpG-free 
expression vector reduced CpG mediated inflammation and resulted in stable in vivo 
transgene expression (Hyde et al., 2008). CpG-free vectors seem to be one possibility to avoid 
methylation dependent transgene silencing. However, other epigenetic events such as 
repressive histone marks still may arise and lead to silencing.  
 
 
 
Understanding of the sequence of epigenetic key events in gene silencing 
that shut down transgene expression would help to circumvent repressive 
mechanisms to obtain stable transgene expression. Moreover, this 
understanding would advance research in cancer and epigenetic 
reprogramming. 
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2. Results 
 
 
 
Table 2.1 Overview of the subsections described in chapter 2. Most of the data are summarized in the publications listed 
below. The contributions are explained in chapter 4.2. 
Chapter Title Data Page
2.1 A Mutagenesis Strategy Combining 
Systematic 
Alanine Scanning with Larger Mutations 
to Study Protein Interactions 
publication in “Analytical 
Biochemistry” 
27 
2.2 Biochemical Analysis of Intramolecular N-C 
Terminal Dnmt1 Interactions 
unpublished data 36 
2.3 Dimerization of DNA Methyltransferase 1 is 
Mediated by its Regulatory Domain 
accepted publication at the 
“Journal of Cellular 
Biochemistry” 
41 
2.4 Np95 Controls Maintenance of DNA 
Methylation by Interaction with DNA 
Methyltransferase 1 
unpublished data 68 
2.5 Np95 Interacts with de novo DNA 
Methyltransferases Dnmt3a and 3b and 
Mediates Epigenetic Silencing 
publication under revision 
at “EMBO Reports” 
77 
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A mutagenesis strategy combining systematic alanine scanning
with larger mutations to study protein interactions
Karin Fellinger, Heinrich Leonhardt, Fabio Spada *
Department of Biology and Munich Center for Integrated Protein Science, Ludwig Maximilians University Munich, 82152 Planegg-Martinsried, Germany
Received 13 September 2007
Available online 18 October 2007
Site-directed mutagenesis (SDM)1 of target DNA is an
invaluable tool to study protein structure–function rela-
tionships. Alanine-scanning mutagenesis has been success-
fully applied to systematically map functional binding
epitopes [1–3]. Substitution of target amino acids with ala-
nine removes all side chain atoms past the b-carbon and
does not introduce unusual backbone dihedral angle pref-
erences. Therefore, alanine scanning is particularly useful
for assessing the contribution of charged residues on the
protein surface without disrupting the folding of its core.
This approach requires the production of large numbers
of point mutants by SDM. Numerous SDM methods have
been described (reviewed in Refs. [4,5]), and commercially
available kits oﬀer fast protocols based on oligonucleotide
primers harboring the mutation [6]. However, most strate-
gies do not include a selectable marker to distinguish mu-
tant clones from wild-type clones and when they do so
the procedure becomes signiﬁcantly more laborious and
time-consuming, as it requires either two cycles of transfor-
mation in diﬀerent bacterial strains [7,8] or transfer of the
target DNA sequence to and from a specialized vector.
In addition, most of these procedures are not suited to gen-
erate large sequence alterations. Methods based on type IIs
restriction enzymes allow precise replacement of individual
nucleotides or codons [9] and either selection for mutant
clones [10] or generation of larger mutations [11], but not
both possibilities together. Again, when selection for mu-
tant clones is possible, multiple restriction, ligation, ﬁll-in
and transformation reactions are necessary and suitable
restriction sites relatively close to the mutagenesis site are
required [10]. Other PCR-based approaches allow genera-
tion of point and larger mutations and rapid screening
for mutant clones but involve ampliﬁcation of the entire
plasmid with consequent risk of introducing additional
mutations [12]. Here we describe a simple, fast and inex-
pensive strategy to generate alanine substitutions as well
as deletions, duplications, insertions or larger replacements
while retaining the ability to screen for mutant clones by
restriction analysis.
The threemajor steps of ourmutagenesis strategy are out-
lined in Fig. 1. Single, double or triple alanine substitutions
are introduced at multiple sites of a deﬁned DNA region
by performing (i) two independent sets of PCR reactions
(PCR1andPCR2 inFig. 1A), (ii) restriction of the PCR frag-
ments and (iii) triple ligation of the two sets of PCR frag-
ments into a suitable vector and transformation. For each
mutation, both a reverse and a forward mutagenic primer
are required. The 3 0 regions of these primers match the se-
quence directly upstream and downstream to the codons
coding for the residues to be exchanged to alanine, respec-
tively, while the overlapping 5 0 tails of the primers harbor a
SacII or NotI site that encodes the alanine residue(s)
(Fig. 1). In addition, both a forward and a reverse primer
are designed ﬂanking the entire sequence where the set of
mutations are to be introduced. These shared ﬂanking prim-
ers have 5 0 tails harboring distinct restriction sites (desig-
nated E1 and E2 in Fig. 1A) to be used for subsequent
cloning in a suitable vector. In one set of PCR reactions,
the ﬂanking forwardprimer is combinedwith distinct reverse
mutagenic primers, whereas in the other set of ampliﬁca-
tions, the forward mutagenic primers and the reverse ﬂank-
ing primer are employed. The two sets of PCR reactions
may be performed simultaneously depending on the anneal-
ing temperature of the primers. The two sets of PCR frag-
ments are then digested with the restriction enzyme
corresponding to the mutagenic restriction site and the
respective enzyme whose site is present at the opposite end
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of each fragment. Fragment pairs to generate a given substi-
tution are then joined into an appropriate vector by a three-
fragment ligation. After transformation, randomly selected
clones can be screened by simple restriction analysis, with
the enzyme recognizing the mutagenic site and one or more
suitable enzymes (Fig. 2).
When a NotI site is used three adjacent residues are ex-
changed to alanines, whereas when a SacII site is used it is
possible to accommodate codons for alanine, serine, threo-
nine or proline in the ﬁrst position and alanine, glycine,
glutamine, valine aspartate in the third position (Fig. 1B).
With the same approach other restriction sites may be
employed according to the speciﬁc amino acid substitutions
required. A major advantage of this strategy is that frag-
ments used to introduce the same mutagenic restriction site
at diﬀerent positions can be combined to generate deletions
and duplications (Fig. 1C). The residues chosen for the
mutagenesis will replace the deleted region and be present
at the junction between the repeats, respectively. When sev-
eral mutagenic sites are planned a large number of dele-
tions can be generated covering diﬀerent parts of the
region. In addition, insertions or larger substitutions can
be generated at one or between two mutagenic sites by
introducing a DNA fragment whose ends are compatible
with the chosen mutagenic restriction site(s). Such frag-
ments may be easily obtained by annealing complementary
synthetic oligonucleotides or by PCR. In addition, when
mutations are introduced in diﬀerent members of a protein
family it is possible to generate chimeric proteins where do-
mains or peptide elements are swapped.
We used our mutagenesis strategy as part of an eﬀort to
characterize potential inter- and intramolecular interactions
mediatedby theTSdomain [13,14] of themurineDNAmeth-
yltransferase 1 (Dnmt1). Eight triple alanine substitutions
were designed at positions corresponding to either peaks or
minima in the hydrophilicity plot of the target region (Figs.
2Aand2BandSupplementaryTable 1). The restriction anal-
ysis of these mutants is shown in Fig. 2C. The mutants were
generated in parallel and more than 90% of the clones tested
positive by SacII restriction analysis in each case. In addi-
tion,we generated adeletionwhere aa 553–578were replaced
by three alanine residues by combining the PCR fragments
upstream and downstream to the EDS(553–555)AAA and
DDE(576–578)AAA mutations, respectively. The sites at the
endpoints of the deletion correspond to consecutive hydro-
philic peaks (Fig. 2A) and were selected with the aim of not
disrupting the overall folding of the domain. We found that
the postreplicative methyltransferase activity of this deletion
mutant in living cells is comparable to that of wild-type
Dnmt1 (Supplementary Fig. 1). Interestingly, a set of less
speciﬁcally targeted deletions in this region was described
previously [15], where all of the deletions either overlapping
or immediately adjacent to the one described here had dele-
terious eﬀects on the catalytic activity, suggesting that the
integrity of structural motifs in this region is crucial for cor-
rect protein folding. Thus, our strategy allowed precise dele-
tion of a distinct structural element without disrupting the
overall folding of the protein. This method proved to be very
robust in that it was successfully applied not only in our
hands but also by inexperienced biology students in the
context of a practical course in molecular biology.
In conclusion, our mutagenesis approach oﬀers a simple
method for systematic generation of alanine mutants and
Fig. 1. Outline of the mutagenesis strategy. (A) Schematic representation
of the three steps involved in the procedure. E1 and E2 represent
restriction endonuclease sites of choice. The use of the SacII restriction site
coding for three alanine residues is exempliﬁed. (B) Illustration of the
introduction of the NotI and SacII restriction sites in the reading frame to
generate triple, double, or single alanine substitutions with all possible
choices of adjacent residues. (C) Schematic drawing of the derivation of
deletion, replacement, duplication, and insertion mutants from PCR
fragments used to generate individual (alanine) substitutions. E1 and E2
represent the restriction sites in the ﬂanking primers.
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fast and inexpensive screening of clones. In addition, sets of
larger mutations, such as deletions, insertions, replace-
ments and duplications can be generated in parallel with
the same reagents used for generation of alanine mutations.
This strategy allows rapid construction of well-designed
sets of mutants for systematic protein analysis.
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SUPPLEMENTARY DATA 
Supplementary table 1. Oligonucleotide primers used in this study for the triple alanine-
scanning mutagenesis of the TS domain from murine Dnmt1. 
Mutation 
PCR1 
Reverse mutagenic Primers 
PCR2 
Forward mutagenic primers 
EDS(553-555)AAA TGC CGC GGC TGT GAA CCG GTT CAC-3’ GCC GCG GCA CTC TTA CGC CAC GCC CAG-3’ 
VVS(563-565)AAA GTAT TGC CGC GGC AAA CTG GGC GTG GCG GAAG GCC GCG GCA CAG GTA GAG AGT TAC GAC 
DDE(576-578)AAA GAAG TGC CGC GGC GTC CTT GGC TTC GTC G GAAG GCC GCG GCA ACC CCC ATC TTC TTG  
CMR(586-588)AAA GAAG TGC CGC GGC GGG AGA CAA GAA GAT GGG GAAG GCC GCG GCA GCC CTG ATC CAT TTG GC 
GVS(595-597)AAA GGGG TGC CGC GGC AGC CAA ATG GAT CAG GG GAAT GCC GCG GCA CTG GGA CAG AGG CGA GC 
GQR(599-601)AAA GTAT TGC CGC GGC CAG GGA GAC ACC AGC GAAT GCC GCG GCA CGA GCA ACA AGG CGC G 
RRV(605-607)AAA GAAG TGC CGC GGC TGT TGC TCG CCT CTG GAAG GCC GCG GCA ATG GGT GCT ACC AAG G 
KAP(616-618)AAA GGGG TGC CGC GGC GTC CTT CTC CTT GGT AG GGGG GCC GCG GCA ACG AAA GCC ACC ACC AC 
 Forward flanking primer (G310-D315) Reverse flanking primer (T624-Q629) 
 
GGGG TG TAC AAG GCG ATC GCA GAG GAC AGA 
GAC GAG G 
GAAG CC CGG GGC GGC CGC TTA CTG ATA GAC 
CAG CTT G 
 
For each reverse and forward mutagenic primer the exchanged amino acids and their positions 
are indicated (left column) and the sequence encoding the three alanines is underlined and the 
sacII site is in bold face. The sequences complementary to the plasmid template in the 
forward and reverse flanking primers are italicized and the positions of the corresponding 
amino acids are indicated, while the BsrGI and XmaI sites used for subcloning are in bold 
face.
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Supplementary Figure 1. GFP-Dnmt1Δ553-578 is catalytically active in vivo. (A) A 
GFP-Dnmt1 fusion construct where aa 553-578 of Dnmt1 were substituted with three alanine 
residues (GFP-Dnmt1Δ553-578) or the corresponding wild type construct (GFP-Dnmt1wt) were 
co-expressed in C2C12 mouse myoblasts with a RFP-PCNA construct as a replication foci 
(RF) marker (red;1). The postreplicative methyltransferase activity of the two Dnmt1 
constructs (green) was compared using a simplified variation of our live cell trapping assay 
(3,4). Briefly, transfected cultures were incubated with and without (control) the mechanism 
based inhibitor 5-aza-2’-deoxycytidine (5-aza-dC) prior to fixation. This deoxycytidine (dC) 
analogue is incorporated into newly synthesized DNA at RF. Dnmt1 interacts directly but 
transiently with PCNA at RF (yellow signal) and is engaged in methylation of hemi-
methylated CpG sites as they are generated during DNA replication (2). As part of its 
catalytic mechanism Dnmt1 forms a transient covalent bond with the cytidine ring which is 
released after methylation, but when dC is replaced by 5-aza-dC this covalent bond cannot be 
resolved and Dnmt1 is permanently “trapped” at the site of action. This leads to complete 
Fellinger et al., Supplementary data 
immobilization of the GFP-Dnmt1 pool in about 40 min (2). Thus, while RFP-PCNA 
dissociates from fully replicated replicons and associates at new, adjacent RF (5), all 
GFP-Dnmt1 remains trapped at sites that are distinct from current RF, resulting in separation 
of red RF from green GFP-Dnmt1 foci. As immobilization is strictly dependent on enzymatic 
activity (3), the similar separation of green and red foci observed with GFP-Dnmt1wt and 
GFP-Dnmt1Δ553-578 indicates that they are comparably active. Scale bar 5 µm. 
(B) Model of how deletion between two hydrophilic patches may result in precise removal of 
a distinct structural element without disrupting the overall protein folding. 
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2.2 Biochemical Analysis of Intramolecular N-C Terminal Dnmt1 
Interactions 
Among the family of DNA methyltransferases Dnmt1 is the only enzyme that possesses a 
large regulatory N-terminal domain of 1111 amino acids which is connected via a (GK)7 linker 
to the catalytic domain. This unique N-terminal region is indispensable for the allosteric 
activation of the catalytic domain as the catalytic domain alone is not enzymatically active 
even though it contains all conserved methyltransferase motifs known from bacterial 
enzymes (Fatemi et al., 2001; Margot et al., 2003). 
2.2.1 A Major Part of the N-Terminal Regulatory Domain is Necessary for Interaction 
with the C-Terminal Catalytic Domain 
To understand the intramolecular regulation of Dnmt1 we mapped subdomains within the N-
terminus that are essential for the interaction with the catalytic domain and therefore 
catalysis. To this end we performed co-immunoprecipitation experiments using the GFP-
Nanotrap (Rothbauer et al., 2008). GFP-N-terminal Dnmt1 fragments were co-expressed with 
Cherry-C-terminal domain, precipitated with GFP-Nanotrap and input and bound fractions 
were analyzed by SDS-PAGE and immunoblotting (Figure 2.1; procedure as described in 
Fellinger et al, 2009). 
 
Figure 2.1 N-C terminal interactions of Dnmt1 were tested by co-immunoprecipitation experiments. (A) Schematic 
outline of N-terminal constructs used, subdomains are indicated: PBD, PCNA binding domain; TS, targeting sequence; 
ZnF, CXXC-type zinc finger; BAH1+2, bromo adjacent homology domain 1+2. Numbers in subscript denote first and last 
amino acids in Dnmt1. All depicted constructs contain a N-terminal GFP tag and were co-expressed with Cherry-C-
terminus (C1124-1620) that contains a C-terminal His6 tag. (B) 1% of input (I) and 30% of bound (B) fractions were 
subjected to SDS-PAGE and immunoblot analysis with antibodies against His and GFP. 
GFP-N-terminus G1-1111 precipitated quantitatively Cherry-C-terminus C1124-1620 while the three 
parts of the N-terminus G1-309, G310-629 and G630-1111 did not interact with C1124-1620. Moreover, 
the N-terminal region containing the TS domain and the zinc finger G310-738 was not sufficient 
for interaction with the C-terminus. Deletion of the N-terminal 309 amino acids of the N-
Results 
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terminus (G310-1111) did not impair the interaction between N- and C-terminus of Dnmt1. As 
single subdomains of the N-terminus were not sufficient to interact with the C-terminus, the 
interaction very likely involves the major part of the N-terminus (aa 310-1111). These results 
indicate that the overall folding of the N-terminus is crucial for interaction and allosteric 
activation of the C-terminal catalytic domain. These results are in line with previously 
published data that showed aa 228-1111 as minimal N-terminal domain of Dnmt1 interacting 
with the catalytic domain in a Y2H screen (Margot et al., 2003). In addition, in vitro activity 
tests of Dnmt1 deletion mutants showed that the N-terminal 425 amino acids were 
dispensable for enzymatic activity of Dnmt1 while more C-terminal deletions within the N-
terminus disrupted the catalytic activity (Margot et al., 2000). 
2.2.2 The CXXC Zinc Finger is Dispensable for Dnmt1 N-C Terminal Interaction 
As part of our effort to determine the region of the Dnmt1 N-terminus that is essential for 
interaction and allosteric activation of the catalytic domain, we tested whether the zinc finger 
plays a role in that process as it was indicated by previous publications (Fatemi et al., 2001; 
Pradhan et al., 2008). The Dnmt1 N-terminus contains a CXXC type zinc finger (C is cysteine, X 
is any amino acid; aa 655-696). The mixed lineage leukemia protein (MLL) contains a CXXC 
zinc finger motif that is highly similar to the one in Dnmt1 (Figure 2.2A). Based on the 
structural information of the MLL zinc finger (Allen et al., 2006) we precisely removed this 
distinct zinc finger structure from Dnmt1 without affecting the surrounding protein regions. 
To this end, we performed deletion mutagenesis according to the mutagenesis strategy 
described in chapter 2.1 (Fellinger et al., 2008). Then, we analyzed Dnmt1 N-C terminal 
interactions by co-immunoprecipitation experiments. GFP and Cherry tagged Dnmt1 domains 
were expressed in HEK293T cells; GFP fusions were precipitated with the GFP Nanotrap 
(Rothbauer et al., 2008) and bound proteins were analyzed by SDS-PAGE and 
immunoblotting (procedure as described in Fellinger et al, 2009, Figure 2.2B/C). 
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Figure 2.2 Analysis of the CXXC zinc finger in the Dnmt1 N-C-terminal interaction. (A) Alignment of the CXXC zinc finger 
domain. Cysteines are highlighted in yellow, KFGG motif in red, asterisks mark identical amino acids. Numbers signify 
the amino acid position within the respective protein. NCBI accession numbers are as follows: Dnmt1 (NP_034196); MLL 
(mixed lineage leukemia, NP_001074518); CGBP (CpG binding protein, NM_028868); MBD1 (methyl binding domain 
protein 1, AF120978); FXL19 (F-box and leucine-rich repeat protein 19, Q6PB97); JHD1A (JmjC domain-containing 
histone demethylation protein 1A, P59997). (B) Schematic outline of Dnmt1 constructs used for co-immunoprecipitation 
experiments. Subdomains are indicated: PBD, PCNA binding domain; TS, targeting sequence; ZnF, CXXC-type zinc 
finger; BAH1+2, bromo adjacent homology domain 1+2. Numbers in subscript denote first and last amino acids in 
Dnmt1. All depicted constructs contain a N-terminal GFP tag and were co-expressed with Cherry-C-terminus (C1124-1620) 
that contains a C-terminal His6 tag. (C) 1% of input (I) and 30% of bound (B) fractions of the co-immunoprecipitation 
experiments were subjected to SDS-PAGE and immunoblotting with antibodies against His and GFP. Deletion of the ZnF 
does not affect N-C-terminal interaction. Molecular size markers are indicated on both sides. 
Cherry-C-terminus C1124-1620 was efficiently co-precipitated with the N-terminal domain G1-
1111∆Zn as well as with G1-1111 full-length. Moreover, GFP-Dnmt1 wt (G1-1620) did not interact 
with the isolated catalytic domain indicating that the intramolecular N-C terminal interaction 
within full-length Dnmt1 is favored.  
 
 
 
  
These results show that the CXXC zinc finger does not play a role in the 
intramolecular N-C-terminal interaction of Dnmt1. 
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2.2.3 Impact of Serine 515 Phosphorylation on Dnmt1 N-C Terminal Interaction 
Phosphorylation of serine 515 (S515) was described to be a common posttranslational 
modification of Dnmt1 (Glickman et al., 1997; Goyal et al., 2007). As this S515 is located within 
the TS domain, in the center of the N-terminus, we tested whether this phosphorylation has 
an influence on N-C-terminal interaction of Dnmt1. Thus, we compared a Dnmt1 “P off” 
mutant containing a S515A (alanine) substitution and a “P on” mutant comprising a S515D 
(aspartic acid) substitution with the wt N-terminal domain. The carboxyl group of aspartic 
acid mimics the phosphate group. Again, we performed co-immunoprecipitation experiments 
using the GFP Nanotrap (Figure 2.3; (Rothbauer et al., 2008) by the standard procedure 
described in Fellinger et al, 2009). 
 
Figure 2.3 Co-immunoprecipitation experiments to study the role of S515A phosphorylation in the N-C-terminal Dnmt1 
interaction. (A) Schematic outline of N-terminal Dnmt1 constructs used, subdomains are indicated: PBD, PCNA binding 
domain; TS, targeting sequence; ZnF, CXXC-type zinc finger; BAH1+2, bromo adjacent homology domain 1+2. Numbers 
in subscript denote first and last amino acids in Dnmt1, S515 mutations are marked by red lines. All depicted constructs 
contain a N-terminal GFP tag. (B) G1-1111 wt, S515A and S515D were co-expressed with Cherry-C-terminus (C1124-1620) that 
contains a C-terminal His6 tag. 1% of input (I) and 30% of bound (B) fractions of the co-immunoprecipitation 
experiments were subjected to SDS-PAGE and immunoblotting with antibodies against Cherry (Rottach et al., 2008) and 
GFP. In contrast to S515D mutation, S515A substitution does not affect N-C-terminal interaction. Molecular size markers 
are indicated on both sides. 
Both GFP-N-terminus wt and S515A co-precipitated the catalytic domain C1124-1620 while the 
N-terminal domain containing the “P on” mutant S515D only weakly interacted with the 
catalytic domain. To date, it is unknown how the phosphorylation of Dnmt1 is regulated. 
However, comparing the wildtype and S515A mutation we did not observe any differences in 
N-C terminal interaction. The S515D substitution, mimicking a phosphate group even had a 
negative effect on N-C-terminal interaction pointing to a tight regulation of this transient 
posttranslational modification. In addition, normal catalytic activity of both S515 mutants in 
the context of full-length Dnmt1 was confirmed using the in vivo trapping assay (unpublished 
data from A. Rottach).  
 
  
The results indicate that phosphorylation of serine 515 is not crucial for the 
interaction between the regulatory N-terminal and the catalytic C-terminal 
domain of Dnmt1. 
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ABSTRACT 
DNA methylation is a major epigenetic modification and plays a crucial role in the regulation 
of gene expression. Within the family of DNA methyltransferases (Dnmts), Dnmt3a and 3b 
establish methylation marks during early development, while Dnmt1 maintains methylation 
patterns after DNA replication. The maintenance function of Dnmt1 is regulated by its large 
regulatory N-terminal domain that interacts with other chromatin factors and is essential for 
the recognition of hemi-methylated DNA. Gelfiltration analysis showed that purified Dnmt1 
elutes at an apparent molecular weight corresponding to the size of a dimer. With protein 
interaction assays we could show that Dnmt1 interacts with itself through its N-terminal 
regulatory domain. By deletion analysis and co-immunoprecipitations we mapped the 
dimerization domain to the targeting sequence TS that is located in the center of the N-
terminal domain (amino acids 310-629) and was previously shown to mediate replication 
independent association with heterochromatin at chromocenters. Further mutational analyses 
suggested that the dimeric complex has a bipartite interaction interface and is formed in a 
head-to-head orientation. Dnmt1 dimer formation could facilitate the discrimination of hemi-
methylated target sites as has been found for other palindromic DNA sequence recognizing 
enzymes. These results assign an additional function to the TS domain and raise the 
interesting question how these functions are spatially and temporarily co-ordinated. 
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INTRODUCTION 
DNA methylation at cytosine residues of CpG dinucleotides is a crucial epigenetic 
modification that regulates gene expression and chromatin structure and is required for X 
chromosome inactivation and imprinting [Bird, 2002; Leonhardt and Cardoso, 2000]. In early 
development new methylation patterns are established by de novo methyltransferases 
Dnmt3a and 3b and are subsequently maintained by DNA methyltransferase1 (Dnmt1) [Goll 
and Bestor, 2005; Hermann et al., 2004]. Dnmt1 is the only methyltransferase with a 
preference for hemi-methylated DNA [Bestor and Ingram, 1983; Pradhan et al., 1999] 
generated by DNA replication and repair. Targeted disruption of the dnmt1 gene leads to 
genome-wide loss of DNA methylation and embryonic lethality [Li et al., 1992]. Artificial 
reduction of cellular Dnmt1 levels severely affects development and genome stability [Gaudet 
et al., 2003; Gaudet et al., 2004]. The crucial role of Dnmt1 was recently also shown in human 
cells [Easwaran et al., 2004; Egger et al., 2006; Spada et al., 2007]. During S-phase Dnmt1 
associates with the replication machinery by interacting with PCNA [Chuang et al., 1997; 
Leonhardt et al., 1992]. PCNA also targets Dnmt1 to DNA repair sites to restore the 
epigenetic information [Mortusewicz et al., 2005]. The interaction of Dnmt1 with the 
replication machinery enhances methylation efficiency by twofold, but is not strictly required 
for postreplicative maintenance of DNA methylation [Schermelleh et al., 2007; Spada et al., 
2007]. The targeting sequence (TS domain) recruits Dnmt1 to pericentric heterochromatin 
independent of DNA replication, H3K9 trimethylation and the interacting proteins SUV39H1 
and HP1 [Easwaran et al., 2004]. Both, the PCNA binding domain PBD and the 
heterochromatin binding TS domain, reside in the large N-terminal part of Dnmt1, a region 
of the protein that contains several regulatory functions and is unique among the family of 
DNA methyltransferases. The intramolecular interaction between the regulatory N-terminus 
and the catalytic C-terminus is essential for the catalytic activity of Dnmt1. Despite the 
presence of all typical, conserved methyltransferase motifs, the catalytic domain per se lacks 
methyltransferase activity [Fatemi et al., 2001; Margot et al., 2000; Margot et al., 2003; 
Zimmermann et al., 1997]. Also, interaction of Dnmt1 with the chromatin factors Np95, LSH, 
EZH2 and G9a was shown to be essential for maintenance of DNA methylation [Bostick et al., 
2007; Esteve et al., 2006; Myant and Stancheva, 2008; Sharif et al., 2007; Vire et al., 2006]. The 
molecular mechanism of these multiple interactions controlling the activity of Dnmt1 and the 
recognition of hemi-methylated target sites remains largely unknown. 
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Our biochemical characterization shows that Dnmt1 forms a stable dimer. With gelfiltration, 
co-immunoprecipitation and in vivo assays we demonstrate that Dnmt1 dimerization is 
mediated by the N-terminal TS domain. These results show that the TS domain is not only 
crucial for recruitment of Dnmt1 to heterochromatin as reported previously, but also for the 
assembly of stable dimeric Dnmt1 complexes. 
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MATERIALS AND METHODS 
Expression Constructs 
The expression construct for GFP-Dnmt1 was described previously [Easwaran et al., 2004]. 
GFP-Dnmt1 fusion constructs were generated by PCR cloning using eGFP-Dnmt1 as template 
to clone into pEGFP-N1 (Clontech) employing either the restriction sites XhoI and XmaI or 
BsrGI and HindIII. GFP was subsequently replaced with mCherry (kindly provided by R.Y. Tsien 
[Shaner et al., 2004]). Throughout this study we used the enhanced GFP and monomeric 
Cherry. PCR primers are listed in supplementary table 1. All constructs were sequenced and 
tested by transient expression in human embryonic kidney (HEK) 293T cells followed by 
immunoblot analysis. hTS was cloned into pMAL-2cX (NEB) after replacement of factor Xa 
cleavage site through a TEV cleavage site. 
Cell Culture, Transfection and Microscopy 
HEK 293T HeLa and BHK cells were cultured in DMEM supplemented with 10% fetal calf 
serum and 50 µg/ml gentamycine. BHK cells carrying a lac operator array were maintained in 
the presence of 150 μg/ml hygromycin B (PAA Laboratories) [Tsukamoto et al., 2000]. HEK 
293T cells were transfected with polyethyleneimine (Sigma). For microscopy, BHK cells were 
grown to 50-70% confluence on glass coverslips and co-transfected with TS-LacI-RFP and 
GFP-Dnmt1 constructs using Transfectin (Bio-Rad) according to manufacturer’s instructions. 
Cells were fixed 24 hr after transfection with 3.7% formaldehyde in PBS for 10 min at room 
temperature. After permeabilization with 0.2% Triton X-100 in PBS for 3 min cells were 
counterstaind with DAPI and mounted in Vectashield (Vector Laboratories). Microscopy was 
performed as described [Zolghadr et al., 2008]. 
Co-Immunoprecipitation and Immunoblotting and Quantification 
HEK 293T cells were transiently transfected with expression plasmids as described above. 
After 24 hr, 60-90% of the cells expressed the constructs as determined by fluorescence 
microscopy. About ~ 1 x 107 cells were harvested in 200 µl of lysis buffer (20 mM Tris/HCl pH 
7.5, 150 mM or 1 M NaCl, 0.5 mM EDTA, 2 mM PMSF, 0.5% NP40). After clearing by 
centrifugation (10 min, 20,000xg, 4°C) supernatants were adjusted to a volume of 500 µl with 
dilution buffer (lysis buffer without NP40). 50 µl aliquots were prepared in SDS-containing 
sample buffer (referred to as input (I)). Extracts were incubated with GFP Nanotrap 
[Rothbauer et al., 2008] (Chromotek) for 2 h at 4°C with constant mixing. Immunocomplexes 
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were harvested by centrifugation (2 min, 5,000xg, 4°C) and beads were washed twice with 1 
ml of dilution buffer containing 300 mM NaCl and resuspended in SDS-PAGE sample buffer 
(referred to a bound (B)). Proteins were eluted by boiling at 95°C. For immunoblot analysis 
1% of the input and 20% of the bound fractions were separated by SDS–PAGE and blotted 
onto a PVDF-membrane (Millipore). Antigens were detected with a mouse monoclonal anti-
GFP antibody (Roche), a rat monoclonal anti-mCherry antibody [Rottach et al., 2008] or a rat 
monoclonal anti-DNMT1 antibody [Spada et al., 2007]. For quantification mean grey values of 
band intensities of co-precipitated proteins obtained from westernblots were calculated with 
the ImageJ software (Version 1.38, http://rsb.info.nih.gov/ij/). The ratios of bound and input 
signals were determined and the mean value and standard error from three independent 
experiments were calculated. 
Gelfiltration 
Reference gelfiltration was carried out with a Superose 6 column and separation properties 
were determined in a first run with mass standard proteins (thyroglobulin (669kDa), 
apoferritin (443kDa), BSA (66kDa)). For analysis of endogenous Dnmt1, HeLa cells were lysed 
in 200 µl of buffer (20 mM Tris/HCl pH 7.5, 50 mM NaCl, 0.5 mM EDTA, 2 mM PMSF, 0.5 mM 
NP40, 1µg/µl DNase I, 5 mM MgCl2), incubated on ice for 30 min and centrifuged (15 min, 
20,000xg, 4°C). The supernatant was adjusted to 500 µl with PBS and applied to a Superose 6 
gelfiltration column (GE Healthcare) (Figure1). Recombinant human Dnmt1 and TS proteins 
were analyzed by a Superdex 200 column (GE Healthcare) (Figure 3) in buffer containing 20 
mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM DTT. Chromatography was performed 
with a flow rate of 0.5 ml/min and fractions were analyzed by SDS-PAGE and immunoblotting 
with an antibody against human DNMT1. 
Protein Purification 
DNMT1 containing an N-terminal His tag was purified from baculovirus infected Sf21 insect 
cells and purified by Ni-NTA chromatography as described previously [Yokochi and 
Robertson, 2002]. The DNMT1 virus was kindly provided by K.D. Robertson. DNMT1 was 
further purified on a Resource Q column (GE Healthcare) with a linear gradient from 100 – 
600 mM NaCl in 20 mM Hepes, pH 7.9; 1 mM EDTA; 1.5 mM MgCl2; 10% Glycerol; 1 mM DTT, 
1 mM PMSF. The peak fractions were combined and stored at -80°C. The DNMT1 TS domain 
(pMAL-TS) was expressed in E.coli K12 TB1 cells (NEB) according to the manufacturer’s 
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instructions. Protein expression was induced at an OD600 of 0.7 with 0.3 mM IPTG for 2 hours, 
cells were harvested and washed once with TBS. The cell pellet of 1 l culture was resuspended 
in 30 ml of buffer CV (20 mM Tris pH 7.5, 200 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM 
DTT) and cells were lysed (Branson Sonifier). The lysate was cleared (20,000 g, 4°C, 20 min) 
and incubated with 10 ml amylose resin (NEB). The resin was washed 3x with 50 ml buffer CV 
and applied to a glass column. The MBP-TS fusion protein was eluted with 30 ml elution 
buffer (buffer CV + 10 mM Maltose). The peak fractions were combined and the TS domain 
was cleaved off the MBP moiety by incubation with TEV protease (Invitrogen) at 16°C over 
night. TEV protease and MBP were removed by a Q FF 5 ml column (GE Healthcare) and the 
TS domain was eluted with a step gradient. 
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RESULTS 
Dnmt1 Forms Stable Dimers 
For biochemical characterization we purified (full-length) DNMT1 using a baculovirus 
expression system. Purified DNMT1 was loaded on a gelfiltration column and the elution 
profile was recorded (Figure 1A). Immunoblot analysis of collected fractions showed that 
DNMT1 was eluted in a fraction corresponding to a molecular mass of about 400kDa. This is 
approximately two-fold the molecular mass of DNMT1 (183kDa) indicating the presence of a 
dimeric DNMT1 complex. To analyze DNMT1 complex formation in vivo, we analyzed extracts 
from HeLa cells by gelfiltration and also did not observe a DNMT1 monomer fraction. 
Instead, the endogenous DNMT1 eluted as part of a higher molecular weight complex of 
400-700 kDa which is likely caused by additional protein interactions occuring in living cells. 
The dimeric complex was stable under high salt buffer conditions up to 1 M NaCl. Dimer 
formation was further tested by co-immunoprecipitation experiments. GFP-Dnmt1 was 
expressed in transiently transfected HEK 293T cells and immunoprecipitated using the GFP-
Nanotrap [Rothbauer et al., 2008]. Immunoblot analysis of input and bound fractions showed 
that the endogenous DNMT1 counterpart was efficiently co-precipitated (Figure 1B). 
The N-Terminal TS Domain Mediates Dnmt1 Dimerization 
The gelfiltration and co-immunoprecipitation experiments both indicated that DNMT1 forms 
a stable dimeric complex. To test whether this dimerization is related to the previously 
reported interaction between the N- and C-terminal domain [Fatemi et al., 2001; Margot et 
al., 2003] and to map the domains involved in this dimerization, we fused various parts of 
Dnmt1 with GFP and Cherry (Figure 2A) and performed co-immunoprecipitation studies. We 
found that the TS domain was sufficient to precipitate the endogenous DNMT1 (Figure 1C). 
To identify the part of Dnmt1 the TS domain binds to we co-expressed different GFP-Dnmt1 
subdomains with Cherry-TS (C310-629) in HEK 293T cells and performed co-
immunoprecipitation. Input and bound fractions were analyzed by immunoblots against GFP 
and Cherry (Figure 2A). GFP-N-terminus (G1-1111) but not GFP-C-terminus (G1124-1620) efficiently 
precipitated the TS domain C310-629 pointing to a dimerization through the N-termini of two 
Dnmt1 molecules rather than an intermolecular interaction between the N- and C-terminal 
domain (Figure 2B). Further fine-mapping showed that the TS domain C310-629 efficiently co-
precipitated with GFP-TS G310-629 but not with G1-309 or G630-1111 (Figure 2b). These results show 
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that Dnmt1 dimerization is mediated through a homotypic interaction of the N-terminal TS 
domain. 
To independently verify these biochemical data in vivo, we performed a fluorescent two-
hybrid assay (F2H), that allows direct visualization of protein interactions in single living cells 
[Zolghadr et al., 2008]. The F2H assay visualizes the interaction of a red fluorescent bait with a 
green fluorescent prey protein as co-localization at a defined nuclear spot. To anchor the 
fluorescent bait, we used a transgenic cell-line that contains a chromosomally integrated lac 
operator array and provides a defined binding platform for Lac repressor fusion proteins. We 
engineered a triple fusion protein comprising the TS domain as bait, the Lac repressor and 
the red fluorescent protein (RFP). Binding of the fusion protein (TS-LacI-RFP) to the lac 
operator array can directly be visualized as defined nuclear spot in living cells by fluorescence 
microscopy (Figure 2C). Interaction of green fluorescent prey proteins with the TS domain 
leads to a co-localization at the anchor point (Figure 2C, right panel) that is visible in the 
overlay as orange/yellow spot. With this assay we tested different Dnmt1 domains for 
interaction with the TS domain containing bait construct. We observed a clear co-localization 
of the N-terminal domain (G1-1111) with the TS-LacI-RFP bait protein while the C-terminal 
domain (G1124-1620) did not co-localize (Figure 2C). To fine-map the interaction with the TS 
domain three parts of the N-terminal domain were tested and only G310-629 showed co-
localization with TS-LacI-RFP while the first and the last part (G1-309 or G630-1111) did not 
interact and showed a diffuse distribution. These results show that the red labeled TS domain 
interacts with green labeled TS domain in vivo. In summary, biochemical and cellular assays 
indicate that Dnmt1 dimerization is mediated by a direct intermolecular TS-TS domain 
interaction. 
Dnmt1 Dimerization is Formed by a Rather Hydrophobic TS-TS Interaction 
To test the complex formation properties we purified the TS domain that has a calculated 
molecular weight of about 30 kDa and analyzed it by gelfiltration. Immunoblot analysis of 
elution fractions showed a distinct peak at about 66 kDa corresponding to a TS dimer and 
high molecular weight complexes in the size range above 500 kDa indicating multimerization 
of the TS domain (Figure 3A, lane 2). This supports the conclusion that the TS domain by 
itself can form a stable dimer and thus drive dimerization of DNMT1. 
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To analyze the nature and strength of this interaction, we performed co-immunoprecipitions 
of GFP-TS and Cherry-TS in the presence of increasing salt concentrations. We found that the 
interaction was stable despite the high ionic strength of the buffer containing 1M NaCl 
(Figure 3B) arguing for a more hydrophobic interaction. Indeed, the hydrophilicity plot [Hopp 
and Woods, 1981] of Dnmt1 shows that the TS domain is among the most hydrophobic parts 
of the regulatory domain of Dnmt1 (Figure 3C). Taken together, these results indicate that the 
dimerization of Dnmt1 is mediated by a stable and rather hydrophobic interaction of the N-
terminal TS domain. 
Dnmt1 Dimerization is Mediated by a Bipartite Interface 
To fine-map the dimerization interface we generated a series of GFP-TS deletion constructs 
including N- and C-terminal deletions in steps of about 50 amino acids. HEK 293T cells were 
co-transfected with GFP-TS deletion constructs and Cherry-TS (C310-629) and co-precipitation 
experiments were performed. Surprisingly, all tested GFP-TS deletion proteins interacted with 
the Cherry-TS full-length domain (Supplementary Figure 1) indicating a more complex and 
potentially multipartite interaction interface.  
To further investigate the interacting regions of the domain, we generated additional GFP- 
and Cherry fusion proteins and tested interactions by co-immunoprecipitations (Figure 4A). 
Pairs of TS subdomain constructs tested are depicted on the left side and their relative co-
immunoprecipitation efficiency is shown in the bar graph on the right side. One 
representative immunoblot is displayed in Figure 4B. We observed no interaction between 
the N- and C-terminal parts of the TS domain (lane 3) arguing against a head-to-tail 
interaction. Interestingly, N- and C-terminal parts of the TS domain overlapping by 27 amino 
acids showed a strong interaction (lane 4) indicating that this middle part plays an important 
role in the TS-TS interaction. In addition, we found that the N-terminal part but not the C-
terminal part of the TS domain can dimerize. These results indicate that dimerization is 
mediated by a bipartite interface containing the N-terminal (aa 310-409) and the central part 
(aa 476-502) of the TS domain. It should be noted that the hydrophobic nature of the TS 
domain makes the fine-mapping of the dimerization interface difficult and may lead to false-
positive results. Further alanine scanning mutagenesis [Fellinger et al., 2008] of the TS domain 
did not yield specific dimerization mutants (data not shown) which is probably due to the 
large bipartite interaction surface spanning almost 200 amino acids. 
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Larger deletions within the TS domain were previously shown to abolish catalytic activity of 
Dnmt1 (Figure 5A, Margot et al, 2000; Zimmermann et al, 1997) emphasizing the importance 
of the TS domain. However, it is unclear to what extent this is due to disruption of 
dimerization, since the TS domain also mediates association with heterochromatin [Easwaran 
et al., 2004] and may also contribute to the allosteric activation of the catalytic domain 
[Fatemi et al., 2001; Margot et al., 2000].  
Interestingly, sequence alignments of Dnmt1 homologs showed that the core region of the 
TS domain that is involved in dimerization is highly conserved from human to plants (Figure 
5A). The crystal structure shows that the conserved core region consists of three β-sheets 
forming part of a potential binding pocket in the TS domain (Figure 5B). The high 
conservation and distinct structure of this TS core region suggests an essential role in Dnmt1 
regulation. 
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DISCUSSION 
Recent work has shown that DNA methylation is linked with several other nuclear processes 
and involves numerous protein interactions. Analyzing recombinant and endogenous Dnmt1 
protein fractions we found that Dnmt1 forms a stable dimer. We mapped the dimerization 
domain to the N-terminal TS domain of Dnmt1 using gelfiltration, co-immunoprecipitation 
and in vivo fluorescent two-hybrid assay. Fine-mapping identified a homotypic TS-TS 
interaction containing a bipartite dimerization interface spanning about 200 amino acids of 
the TS domain.  
Interestingly, dimerization has also been shown for other C5 DNA methyltransferases 
including the bacteria HhaI and the vertebrate Dnmt3a and Dnmt3L [Dong et al., 2004; Jia et 
al., 2007]. The crystal structure revealed that the central Dnmt3a dimer is flanked by Dnmt3L 
forming a 3L-3a-3a-3L tetramer. Disruption of the Dnmt3a dimer by specific point mutations 
resulted in loss of catalytic activity [Jia et al., 2007]. In contrast to these DNA 
methyltransferases that dimerize via the catalytic domain, Dnmt1 dimerization is mediated by 
its unique regulatory, N-terminal domain. Consistent with this difference, the key residues for 
Dnmt3a dimerization (R881 and D872) are not conserved in Dnmt1. In addition to 
dimerization, the TS domain of Dnmt1 also seems to contribute to allosteric activation of the 
catalytic domain [Fatemi et al., 2001; Margot et al., 2000; Zimmermann et al., 1997] and 
mediates association with heterochromatin [Easwaran et al., 2004]. Further studies are 
necessary to elucidate the temporal and spatial coordination of these multiple functions of 
the TS domain. 
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Figure 1 
DNMT1 was analyzed by gelfiltration and co-immunoprecipitation. (A) Elution profile of 
recombinant human DNMT1 showing a peak at ~ 400 kDa, the x-axis indicates the protein 
fractions collected in 1 ml steps and the y-axis presents the absorption units (A.U.) at the 
wavelength of 280 nm. The arrows denote the molecular size of marker proteins applied in a 
separate run (thyroglobulin: 669 kDa, apoferritin 443 kDa, BSA 66 kDa). Immunoblot of 
elution fractions confirms the elution profile of recombinant DNMT1 (upper row). 
Endogenous DNMT1 of a HeLa cell extract is present in a higher molecular weight complex 
(lower row). (B) Immunoblots after co-immunuprecipitations illustrate the interaction 
between GFP-Dnmt1 and endogenous DNMT1, whereas GFP alone was used as negative 
control. 1% of input and 30% of bound fractions were subjected to immunoblot analysis. The 
molecular size of the proteins (kDa) and the antibodies used are indicated. (C) Mapping the 
Dnmt1 dimerization to the TS domain of Dnmt1: Immunoblot after co-immunoprecipitation 
showing that the N-terminal TS domain of Dnmt1 can co-precipitate endogenous DNMT1. 
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Figure 2 
N-terminal TS domain is the Dnmt1 dimerization domain. (A) Schematic overview of Dnmt1 
constructs used for co-immunoprecipitations. Subdomains are indicated: PBD, PCNA binding 
domain; NLS nuclear localization signal; TS, targeting sequence; ZnF, zinc finger; BAH1+2, 
bromo adjacent homology domains 1+2. (B) Immunoblots after co-immunoprecipitations of 
GFP-Dnmt1 domains and Cherry-TS (C310-629) with the GFP-Nanotrap. G indicates GFP and C 
Cherry, numerics in subscript denote the first and last amino acids of Dnmt1 present in these 
constructs. 1% of input (I) and 20% of bound (B) fractions were subjected to SDS-PAGE, 
blotted on PVDF membrane (Millipore) and decorated with antibodies against Cherry and 
GFP. These results are representative of three independent experiments and show that GFP-
N-terminus (G1-1111) and GFP-TS (G310-629) interact with Cherry-TS (C310-629). (C) Fluorescent 
two-hybrid (F2H) assay confirms biochemical interaction data. TS-LacI-RFP (bait, depicted on 
top) was co-expressed with GFP-Dnmt1 domains (prey) in transgenic BHK cells [Tsukamoto et 
al., 2000] containing a lac operator array. Binding of the TS-LacI-RFP fusion protein is visible 
as distinct nuclear spot and interaction of a GFP fusion protein leads to co-localizing 
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fluorescence signals. DAPI, RFP, and GFP were imaged and an overlay image of GFP and RFP 
fluorescence is presented. The Dnmt1 N-terminus (G1-1111) co-localizes with TS-LacI-RFP but 
the C-terminus (G1124-1620) does not. From the three parts of the N-terminal domain only the 
TS domain (G310-629) co-localized with TS-LacI-RFP indicating a specific TS-TS interaction in 
vivo. The scale bar represents 5 μm. 
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Figure 3 
Dnmt1 dimerization is formed by a rather hydrophobic TS-TS interaction. (A) DNMT1 and the 
TS domain were studied by gelfiltration and the respective protein fractions are analyzed by 
immunoblots. The proteins and the migration of the size standards are indicated (in kDa) as 
well as the protein fractions loaded in ml and the input fraction (I). (B) Hydrophilic or 
hydrophobic nature of the dimerization interaction was tested by co-immunoprecipitation of 
GFP-TS (G310-629) and Cherry-TS (C310-629) in buffer containing 1 M NaCl with subsequent 
immunoblot analysis. 1% of input (I) and 20% of bound (B) fractions were loaded and 
immunoblots probed with antibodies against GFP and Cherry. (C) Top: Schematic outline of 
Dnmt1 full-length protein including subdomains: PBD (PCNA binding domain), NLS (nuclear 
localization signal). TS (targeting sequence), ZnF (zinc finger), BAH 1 + 2 (bromo adjacent 
homology domains 1 + 2). Bottom: Hydrophilicity plot [Hopp and Woods, 1981] of the 
Dnmt1 protein sequence generated with the ProtScale tool of the ExPASy proteomics server 
(http://www.expasy.ch/tools/protscale.html) with the linear weight variation model and a 15 
amino acid window. Hydrophobic regions are represented as minima in the plot; a rectangle 
marks the TS domain which is rather hydrophobic in comparison with the rest of the N-
terminus. 
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Figure 4 
Fine-Mapping of the TS-TS interactions by co-immunoprecipitation analyses. (A) Left panel: 
Scheme of GFP (open elipse) and Cherry (filled elipse) tagged TS deletion constructs used for 
immunoprecipitation assays: Numbers above the construct refer to respective amino acid 
positions within Dnmt1. Right panel: Bar graph shows relative co-immunoprecipitation rates. 
Westernblot signals from input and bound fractions were quantified with ImageJ and mean 
ratios of three independent experiments +/- standard error (SE) determined. (B) Immunoblot 
from one representative co-immunprecipitation experiment out of three independent 
experiments. Quantification of all three experiments is shown above in A. G indicates GFP, C 
Cherry. 1% of input (I) and 20% of bound (B) fractions were subjected to SDS-PAGE and 
immunoblotting and probed with antibodies against Cherry. Precipitation efficiency of GFP-
proteins was checked by immunoblot analysis with antibodies against GFP (not shown). 
Molecular marker sizes are indicated on the left. 
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Figure 5 
TS domain is crucial for Dnmt1 activity and contains a highly conserved core region. 
(A) Schematic overview of Dnmt1 and subdomains (PBD, PCNA binding domain; TS, 
targeting sequence; ZnF, zinc finger; BAH1+2, bromo adjacent homology domains1+2). 
Below, Dnmt1 deletion mutants and their in vitro activity (left) are shown, results were taken 
from Margot et al., 2000. Below, a magnified overview of the TS domain is depicted with an 
N-terminal part (blue), the highly conserved core (red) and the C-terminal part (green). Black 
lines represent amino acids that are identical in Dnmt1 homologs from human to plants. 
Below, a ClustalW alignment of the central TS region from selected Dnmt1 homologs is 
shown. Identical amino acids are marked by dark gray shading. Red rectangle highlights the 
27 amino acids which are important for TS-TS dimerization. Accession numbers: M. musculus, 
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P13864; R. norwegicus, Q9Z330; B. taurus, Q24K09; O. aries, Q865V5; H. sapiens, P26358; D. 
rerio, Q8QGB8; X. laevis, Q6GQH0; M. domestica, Q8MJ28; G.gallus, Q92072; P. lividus, 
Q27746; B. mori, Q5W7N6; A. thaliana, Q9SEG3; D. carota, O48867; Z. mays, Q8LPU6; O. 
sativa, A2XMY1. (B) Crystal structure of human TS domain (aa 351-600; Protein Data Bank 
3epz). The image was generated using PyMOL (DeLano 2002). The N-terminal part of the TS 
domain is colored in blue and coordinates a zinc-ion, the highly conserved central region in 
orange and red and the C-terminal region in green. The view from two angles shows the 
highly conserved β-sheet structure (orange / red) of the TS domain as part of a potential 
binding pocket. 
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SUPPLEMENTARY INFORMATION 
 
Supplementary Figure 1 
TS-TS Interaction studies by co-immunoprecipitation. (A) Overview illustrating TS domain 
constructs used for TS-TS co-immunoprecipitations. Amino acid numbers are indicated. All 
constructs contain an N–terminal GFP tag and were co-expressed with Cherry-TS (C310-629).  
(B) Immunoblots of co-immunoprecipitation fractions; 1% of input (I) and 20% of bound (B) 
fractions were loaded on 10% SDS-PAGE, protein size standard in kDa is indicated; 
immunoblots were probed with antibodies against Cherry and GFP. 
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Supplementary Table 1 
Oligonucleotide primers applied for PCR cloning of murine Dnmt1 constructs, restriction sites 
are underlined. 
Construct Forward Primer (5’ – 3’) Reverse Primer (5’ – 3’) 
GFP-N(1-1111) GAGACTCGAGGCGATCGCATGCCAGCGCGAACAG GAGACCCGGGTTATGCGGCCGCGTTCCCAGGGCTGCG 
GFP-C(1124-1620) GAGACTCGAGGCGATCGCAAGCATCAGGTGTCAGAG GAGACCCGGGTTATGCGGCCGCGTCCTTGGTAGCAGC 
GFP-N(1-309) GGGGTGTACAAGGCGATCGCAATGCCAGCGCGAACAG GGGGAAGCTTGCGGCCGCTTAGGGAGTCTCTGGAGCTAC 
GFP-TS(310-629) GAGACTCGAGGCGATCGCGAGGACAGAGACGAGG GAGACCCGGGTTATGCGGCCGCCTGATAGACCAGCTTGGTG 
GFP-N(630-1111) GGGGTGACAAGGCGATCGCAATCTTTGACACTTTCTTCTCAGA GGGAAGCTTGCGGCCGCTTAGTTCCCAGGGCTGCG 
Ch-TS(310-629) GGGGTGTACAAGTCCGGACTCAGATCTGAGGACAGAGACGA
GGATG 
GGGGTCTAGACTATTACTGATAGACCAGCTTGGTGG 
GFP-TS(310-410) GAGACTCGAGGCGATCGCGAGGACAGAGACGAGG GAGACCCGGGTTATGCGGCCGCGGGAGAATCTTCATAAG 
GFP-TS(310-475) see primer above GAGACCCGGGTTATGCGGCCGCAAAGCCACTGAGCCAC 
GFP-TS(310-502) see primer above GAGACCCGGGTTATGCGGCCGCCTCATACTCTTTGCTGGG 
GFP-TS(476-629) GAGACTCGAGGCGATCGCGATGGTGGCGAGAAGG GAGACCCGGGTTATGCGGCCGCCTGATAGACCAGCTTGGTG 
GFP-TS(503-629) GAGACTCGAGGCGATCGCCCAATATTTGGGCTGATGCAG see primer above 
GFP-TS(551-629) GAGACTCGAGGCGATCGCTTCACAGAGGACTCCCTCTTACG see primer above 
MBP-TS GGCGAATTCATGGACGAGGATGAAAAGGAGGAGA GCCAAGCTTCTCGAGTTACTTATCGTCGTCATCCTTGTAATCC 
Ch-TS(310-409)    Ch-TS(310-475)          Ch-TS(310-502)         Ch-TS(476-629)     
Ch-TS(503-629)) 
    ChTS(551-629) 
 GAGAGCTAGCGCCACCATGGCTTCGTGGGGATC GAGAGGTGTACAGCTCGTCCATGCCG 
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2.4 Np95 Controls Maintenance of DNA Methylation by Interaction with 
DNA Methyltransferase 1 
Beside the allosteric activation of Dnmt1 through its N-C-terminal interaction and 
dimerization, other chromatin factors are important for the regulation of Dnmt1.  
Np95 was described to bind to chromatin (histones and HDAC1), to possess ubiquitin E3 
ligase activity and to play an important role in cell cycle for S phase entry (Bonapace et al., 
2002; Citterio et al., 2004; Jenkins et al., 2005; Unoki et al., 2004). An overview of the nuclear 
protein (Np) family is provided in Figure 2.4. Several names have been assigned to Np95 such 
as ICBP90 (inverted CCAAT box binding protein of 90 kDa) and UHRF1 (ubiquitin-like, 
containing PHD and RING finger domains 1). 
 
Figure 2.4 Schematic overview of the murine Np protein family. Subdomains are indicated: Ubl, ubiquitin-like domain; 
TUDOR, tandem tudor domain; PHD, plant homeo domain; SRA, SET and RING associated domain; RING, really 
interesting new gene, containing ubiquitin E3 ligase activity. 
Targeted disruption of the np95 gene resulted in global hypomethylation of ESCs, embryonic 
lethality and thus phenocopied the dnmt1-/- knockout (Li et al., 1992; Muto et al., 2002; Sharif 
et al., 2007). Np95 was shown to localize at replication foci (RF) during early and mid S phase 
and to pericentric heterochromatin (PH) from mid S phase to G2 (Papait et al., 2007; Uemura 
et al., 2000). Recently, the co-crystal structure of the Np95 SRA domain and hemi-methylated 
DNA was solved showing the SRA domain flipping out methyl-cytosine from the DNA double 
helix (Arita et al., 2008; Avvakumov et al., 2008; Hashimoto et al., 2008). DNA base flipping is 
a conserved mechanism that is known from nucleotide modifying enzymes, including DNA 
methyltransferases, DNA repair enzymes and RNA modifying enzymes (Cheng and Roberts, 
2001; Klimasauskas et al., 1994; Lee et al., 2005; Min and Pavletich, 2007; Parker et al., 2007; 
Yang et al., 2008). Moreover, Np95 was reported to play a role in methylation maintenance by 
recruiting Dnmt1 to methylated DNA (Bostick et al., 2007; Sharif et al., 2007). To elucidate 
how Np95 regulates DNA methylation and Dnmt1 we analyzed the interacting domains and 
tried to rescue dnmt1-/- ECS with a Dnmt1 construct that cannot interact with Np95. 
Results 
 
 
  69 
2.4.1 Dnmt1 Interacts with Np95 through its Regulatory Domain 
Dnmt1 displays a cell cycle dependent subnuclear distribution that depends on two 
subdomains of the regulatory N-terminal part: The PBD is responsible for Dnmt1 localization 
at RF and the TS domain recruits Dnmt1 to PH (Easwaran et al., 2004; Schermelleh et al., 
2007). To elucidate the role of Np95 in DNA methylation maintenance, we first determined 
the region of Dnmt1 that is responsible for the interaction with Np95. As recent studies 
mapped the interacting regions of Dnmt1 and Np95 to different domains we tried to clarify 
this point (Achour et al., 2008; Bostick et al., 2007; Sharif et al., 2007). To map the interaction 
between Dnmt1 and Np95, we expressed individual GFP-Dnmt1 domains together with Np95 
in HEK293T cells and performed co-immunoprecipitation experiments with the cell lysates 
using the GFP-Nanotrap (Figure 2.5A/B; (Rothbauer et al., 2008)). 
Results 
 
 
70   
 
Figure 2.5 Np95 interacts with the TS domain of Dnmt1. (A) Schematic representation of GFP-Dnmt1 fusion constructs 
used for mapping the interaction site with Np95 (N-terminal GFP tag is not shown). PBD, PCNA binding domain; TS, 
targeting sequence; ZnF, CXXC-type zinc finger; BAH, bromo adjacent homology domain. (B) Co-immunoprecipitation 
of Np95-His with the GFP-Dnmt1 constructs shown in A from extracts of transiently transfected HEK293T cells. G 
indicates the GFP fusion and numbers in subscript indicate amino acid positions in Dnmt1. 1% of input (I) and 70% of 
bound (B) fractions were subjected to SDS-PAGE and immunoblot analysis and proteins detected with an antibody 
against His; molecular size markers are indicated. (C) Domain structure of Dnmt1 and alignment of the conserved core 
of the TS domain from higher eukaryotes. Invariant amino acids are indicated as black lines in the blown up drawing of 
the TS domain and shaded in grey in the alignment. The arrowhead points to the conserved glycine 474, which was 
mutated to glutamate to generate the GFP-Dnmt1G474E construct. Accession numbers: M. musculus: P13864; R. 
norvegicus: Q9Z330; B. taurus: O44952; O. aries: O39704; C. familiaris: P848593; H. sapiens: P26358; D. rerio: Q8QGB8; 
X. helleri: F73200; X. laevis: P79922; M. domestica: Q8MJ28; G. gallus: Q92072; P. lividus: Q27746; B. mori: Q5W7N6; A. 
thaliana: Q9T0I1; D. carota: O48867; Z. mays: Q8LPU6 ; O. sativa: Q8S4C3. (D) Fine mapping of the Np95 interaction site 
within the TS domain. The co-immunoprecipitation scheme and loading of input (I) and bound (B) fractions are as in B. 
Np95 co-precipitated efficiently with the Dnmt1 N-terminus but not with the C-terminus. 
Within the N-terminal region we found robust co-immunoprecipitation of His-tagged Np95 
with the targeting sequence (TS) of Dnmt1, while the fragments upstream and downstream 
to the TS domain showed only very weak and no binding to Np95, respectively. We then 
examined whether the interaction with Np95 is mediated by the highly conserved core of the 
TS domain (Figure 2.5C). The conservative substitution of the invariant glycine 474 with 
glutamate (G474E) drastically diminished binding to Np95 and deletion of the entire 
conserved core from the isolated TS domain (∆459-501) essentially abolished the interaction 
with Np95 (Figure 2.5D). These data indicate that the highly conserved core of the TS domain 
in Dnmt1 is the major binding site for Np95. 
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We confirmed the biochemical interaction data using the F2H assay that allows the analysis 
of protein interactions in living cells (outlined in chapter 1, page 9; (Zolghadr et al., 2008)). 
 
Figure 2.6 Np95 interacts with Dnmt1 TS domain. F2H assay shows clear recruitment of Cherry-Np95 (prey) at the lac 
operator array when GFP-Dnmt1 full-length, the N-terminal domain (G-N1-1111) or the TS domain (G-TS310-629) are used as 
baits (marked by white arrowheads), a very weak recruitment to G-N1-309 but no recruitment to the last third of the N-
termins G-N630-1111 or the catalytic domain (G-C1124-1620). Scale bars represent 5 µm. 
GFP-Dnmt1 fusion constructs were used as baits by tethering them to the lac operator array 
present in BHK cells. Thereby the array was visible as distinct nuclear spot of high GFP 
fluorescence (Figure 2.6). We observed recruitment of Cherry-Np95 (prey) only to the GFP-
Dnmt1 full-length or N-terminus but not to the C-terminus. More specifically, Np95 strongly 
interacted with the Dnmt1 TS domain but only weakly or not with the N- or C-terminal parts 
of the N-terminal domain, respectively.  
 
 
 
Furthermore, we asked which part of Np95 is involved in this contact. Interestingly, the N-
terminal region of Np95 containing the ubiquitin-like domain (aa 1-81) and the tandem tudor 
domain (aa 126-285) was pulled down with GFP-Dnmt1 whereas all other domains (PHD, 
SRA, RING) did not interact with GFP-Dnmt1 (Figure 2.7A/B). To test the involvement of the 
ubiquitin-like domain of Np95 we compared interactions between GFP-Dnmt1 and Np95 
deletion constructs in co-immunoprecipitation experiments as described above. Deletion of 
Taken together, from biochemical and cell biological experiments we can 
conclude that the TS domain of Dnmt1 is the major Np95 interacting 
domain. 
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only the ubiquitin-like domain (Ubl, aa 1-81) almost abolished the interaction with Dnmt1 
(Figure 2.7D). In summary, these results point to an interaction between the ubiquitin-like 
domain of Np95 and the TS domain of Dnmt1. 
 
Figure 2.7 Mapping the Dnmt1-Np95 interaction within Np95. (A+C) Overview of Np95 constructs used for co-
immunoprecipiations presented in (B+D), respectively, C-terminal His tag is not shown. Ubl, ubiquitin-like domain, PHD, 
plant homeo domain; SRA, SET and Ring associated domain; RING, really interesting new gene, containing ubiquitin E3 
ligase activity. (B+D) 1% of input (I) and 80% of bound (B) fractions were loaded and proteins detected with an 
antibody against His. Quantitative precipitation of GFP-Dnmt1 was confirmed by immunoblotting against GFP (not 
shown). 
As Np95 was described to play a major role in maintenance of DNA methylation, we wanted 
to elucidate how it regulates Dnmt1. The mutant GFP-Dnmt1∆459-501 does not interact with 
Np95. Therefore, we asked whether this Dnmt1 mutant first shows a normal cell cycle 
dependent distribution and second whether it is catalytically active. Furthermore, if GFP-
Dnmt1∆459-501 is active, has it the capacity to rescue methylation patterns in dnmt1-/- ESCs 
as GFP-Dnmt1 wt? 
GFP-Dnmt1 wt or GFP-Dnmt1∆459-501 was co-expressed with the replication marker PCNA 
(RFP-PCNA) in C2C12 mouse fibroblast cells and live-cell fluorescence microscopy was 
performed. Both constructs localized normally at replication foci in early and mid-S phase but 
GFP-Dnmt1∆459-501 showed a higher diffuse fraction in late S phase compared to GFP-
Dnmt1 wt (Figure 2.8). However, TS mediated enrichment at PH temporally overlaps with PH 
replication (late S phase) and thus could be masked by the interaction of Dnmt1 with the 
replication machinery. To differentiate between these two phenomena we combined the TS 
mutation with the PBD (Q162E) that abolishes the interaction with PCNA (Schermelleh et al., 
2007). The double mutant displayed a completely diffuse distribution in all cell-cycle stages, 
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clearly indicating that the TS mutation abolishes the accumulation of Dnmt1 at PH (Figure 
2.8C). 
 
Figure 2.8 Localization of GFP-Dnmt1∆459-501 mutants during S phase. Top: Schematic overview of Dnmt1∆459-501 
and Dnmt1Q162E ∆459-501; N-terminal GFP-tag is not shown. PBD, PCNA binding domain; TS, targeting sequence; 
BAH1+2, bromo adjacent homology domains 1+2. (A) Distribution of GFP-Dnmt1 wt and (B) GFP-Dnmt1∆459-501 
during S phase; RFP-PCNA serves as S phase marker. Co-localization of GFP-Dnmt1∆459-501 and RFP-PCNA during 
early and mid S phase but only weak in late S phase. Scale bar represents 5 µm. (C) GFP-Dnmt1Q162E ∆459-501 shows a 
completely diffuse distribution throughout S phase. 
GFP-Dnmt1Q162E∆459-501 - that interacts neither with PCNA nor with Np95 – is not 
recruited to PH. These results indicate that Np95 is responsible for targeting Dnmt1 to PH 
and the question emerged whether this GFP-Dnmt1∆459-501 is catalytically active and 
involved in DNA methylation of genomic targets. To test this, we used the trapping assay 
(Schermelleh et al., 2005). The method is based on the incorporation of a 2’-deoxycytidine 
(dC) analogue 5’-aza-2’-deoxycytidine (5-aza-dC) into the DNA during DNA replication in 
cells co-expressing GFP-Dnmt1 and the S phase marker protein PCNA fused to mRFP (RFP-
PCNA). During the catalytic mechanism of methylation, Dnmt1 forms a transient covalent 
complex with dC and is released after transfer of the methyl group by a β-elimination 
process. However, if 5-aza-dC is incorporated in the DNA instead of dC, the release of Dnmt1 
from the covalent complex with DNA cannot take place and Dnmt1 is captured at the site of 
action. The replication machinery proceeds to new replicons while Dnmt1 is trapped. 
Therefore, a time-dependent separation of the replication foci (monitored by RFP-PCNA) and 
GFP-Dnmt1 can be observed. In other words, only if Dnmt1 is catalytically active, a separation 
of red (RFP-PCNA) and green (GFP-Dnmt1) foci takes place. It was previously published by 
our group that loss of the interaction with PCNA by the Q162E mutation prevents 
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accumulation of GFP-Dnmt1Q162E at replication foci (Schermelleh et al., 2007). Nonetheless, 
incorporation of 5-aza-dC caused accumulation of GFP-Dnmt1Q162E at replication foci and 
kinetic analysis showed that covalent complex formation of GFP-Dnmt1Q162E was reduced 
only by twofold compared to GFP-Dnmt1 wt. Accordingly, we tested the catalytic activity of 
Dnmt1 double mutants that bind neither PCNA nor Np95. Incorporation of 5-aza-dC resulted 
in accumulation of Dnmt1 double mutants at RF throughout S-phase, but kinetic studies 
(FRAP analysis) showed that the formation of distinct foci was 2-3 fold times delayed 
compared to GFP-Dnmt1 wt (Figure 2.9). 
 
Figure 2.9 Trapping assay of GFP-Dnmt1 wt and mutants to analyze the property to form covalent complexes with 
substrate DNA. C2C12 mouse myoblast cells were co-transfected with RFP-PCNA and GFP-Dnmt1 wt or mutants and 
quantitative ROI FRAP analysis (3μm x 3μm) was performed at selected time points after incubation with 5-aza-dC in 
early-mid (left) and late S phase (right). Time dependent increase of immobile fractions of GFP-Dnmt1 wt (green 
triangles), GFP-Dnmt1∆459-501 (red diamonds) and Dnmt1Q162E ∆459-501 (blue dots) is plotted and shows that both 
mutants accumulate at the DNA after 5-aza-dC incorporation but with a delayed kinetic compared to GFP-Dnmt1 wt. 
Hence, disruption of both PCNA and Np95 interaction reduced the rate of postreplicative 
Dnmt1-DNA complex formation during S-phase. Moreover, results of a radioactive DNA 
methyltransferase assay showed normal Dnmt1 activity of the Np95 interaction mutant in 
vitro (not shown). These results suggest that the interaction of Dnmt1 with Np95 may not be 
essential but np95-/- ES cells display a strong hypomethylation of both repetitive sequences 
and single copy genes (Sharif et al., 2007). These reduced methylation levels are highly similar 
to the hypomethylation status in dnmt1-/- ESCs. The genome-wide loss of methylation 
without sequence preference in np95-/- ESCs is surprising since the interaction of Np95 with 
the TS domain of Dnmt1 would suggest a preferential reduction of methylation at pericentric 
satellite sequences. 
Therefore, we tested the ability of the Dnmt1 mutant deficient in Np95 interaction to restore 
methylation patterns in hypomethylated dnmt1-/- ESCs. We stably expressed GFP-
Results 
 
 
  75 
Dnmt1∆459-501 or GFP-Dnmt1 wt in dnmt1-/- ESCs and quantitatively analyzed methylation 
patterns of different types of sequences such as major and minor satellite DNA, retroviral 
elements intracisternal A-type particle (IAP) and single copy genes by pyrosequencing 
(unpublished data from W. Qin). GFP-Dnmt1 wt was able to restore methylation patterns of 
all types of sequences up to almost wildtype methylation levels. However, GFP-Dnmt1∆459-
501 failed to restore methylation patterns of any sequence type.  
 
 
 
  
These results clearly indicate that the interaction of Dnmt1 with Np95 is 
essential for maintenance of methylation patterns in ESCs in vivo. The 
interaction with Np95 seems to target und to permit Dnmt1 to access DNA 
target sites in chromatin. 
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ABSTRACT 
Recent studies indicated that Np95 is essential for maintaining genomic methylation by 
recruiting Dnmt1 to hemi-methylated sites. Here we show that Np95 interacts even stronger 
with the regulatory domains of the de novo DNA methyltransferases Dnmt3a and 3b. To 
investigate possible functions we developed an epigenetic silencing assay with fluorescent 
reporters. We found that genetic inactivation of Np95 in ESCs results in a loss of promoter de 
novo methylation and silencing activity just like the simultaneous inactivation of dnmt1, 
dnmt3a and 3b. These results assign Np95 a previously unrecognised role in epigenetic 
silencing mediated by de novo methyltransferases Dnmt3a and 3b. 
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INTRODUCTION 
In mammals DNA methylation contributes to the establishment and maintenance of cell 
type-specific gene expression programs, imprinting, X chromosome inactivation and genome 
stability (Bird, 2002). The vast majority of genomic methylation occurs at cytosine residues 
within CpG dinucleotides and is catalyzed by the DNA methyltransferases (Dnmt) 1, 3a and 
3b. Dnmt1 is responsible for maintaining genomic methylation, while Dnmt3a and 3b are 
mainly involved in de novo establishment of methylation patterns during cellular 
differentiation (Lei et al., 1996; Leonhardt et al., 1992; Li et al., 1992; Okano et al., 1999). Np95 
(also known as Uhrf1) has recently emerged as an essential cofactor for maintaining genomic 
methylation (Achour et al., 2008; Bostick et al., 2007; Sharif et al., 2007). dnmt1-/- and np95-/- 
embryonic stem cells (ESCs) and embryos have very similarly reduced levels of DNA 
methylation. In addition, Np95 interacts with Dnmt1, binds hemi-methylated CpG sites 
through its SRA (Set and Ring associated) domain and both Np95 and Dnmt1 accumulate at 
replication sites (Arita et al., 2008; Avvakumov et al., 2008; Bostick et al., 2007; Hashimoto et 
al., 2008; Papait et al., 2007; Uemura et al., 2000). Thus, it has been proposed that Np95 
mediates maintenance of genomic methylation by recruiting Dnmt1 to hemi-methylated CpG 
sites generated during replication. 
Here we investigated a possible involvement of Np95 in epigenetic regulation beyond its role 
in Dnmt1 mediated maintenance of DNA methylation. We found that Np95 interacts with the 
de novo methyltransferases Dnmt3a and 3b and mediates promoter de novo methylation and 
epigenetic silencing. 
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RESULTS AND DISCUSSION 
Np95 Interacts with Dnmt3a and 3b 
Immunoprecipitation experiments revealed that different isoforms of both de novo 
methyltransferases Dnmt3a and 3b interact with Np95 in wild type ESCs, including the more 
abundant Dnmt3a2 and Dnmt3b1 (Fig. 1A). Using a GFP nanotrap (Rothbauer et al., 2008), we 
also co-immunoprecipitated endogenous Dnmt3a and Dnmt3b isoforms with a GFP-Np95 
fusion construct transiently expressed in np95-/- ESCs and, vice versa, endogenous Np95 co-
immunoprecipitated with GFP-Dnmt3a or GFP-Dnmt3b1 fusions in dnmt3a and 3b double 
knockout (dnmt3 DKO) ESCs (Supplementary Fig. S1A and B). In addition, we observed co-
immunoprecipitation of endogenous DNMT3b and ICBP90 (the human homolog of Np95) 
from HEK293T cell extracts (Supplementary Fig. S1C). We confirmed the interaction of Np95 
with Dnmt3a/b using a recently developed fluorescent two-hybrid (F2H) assay (Rothbauer et 
al., 2008). GFP-Dnmt3 fusion constructs were used as baits by tethering them to a lac 
operator array present in BHK cells, so that the array was visible as a distinct nuclear spot of 
enriched GFP fluorescence (Fig. 1B). A Cherry-Np95 fusion (prey) accumulated at this spot 
only when GFP fusions of full length Dnmt3a and 3b1 or their N-terminal regions were used 
as baits and not with their isolated C-terminal catalytic domains. We further mapped the 
interaction of Np95 with Dnmt3a/b by co-immunoprecipitation of deletion constructs and 
isolated domains transiently expressed in HEK293T cells (Supplementary Fig. S2). Consistent 
with the results obtained with the F2H assay, the N-terminal regions of Dnmt3a and 3b1, but 
not their C-terminal catalytic domains, interacted with Np95. Deletion of the PHD or the 
PWWP domain of Dnmt3a and 3b did not eliminate the interaction with Np95. We then 
determined which Np95 domains are involved in this interaction. We found that the SRA 
domain and the N-terminal 298 aa of Np95, that include the Ubiquitin-like domain, 
interacted with Dnmt3a and 3b1, while the PHD and the C-terminal 132 aa, including the 
Ring domain, did not.  
To compare the stability of Np95 interactions with different Dnmts we transiently co-
expressed Np95-His with either GFP-Dnmt1, GFP-Dnmt3a or GFP-Dnmt3b1 in HEK293T cells 
and performed immunoprecipitations in the presence of different salt concentrations (Fig. 1C 
and Supplementary Fig. S3). Interestingly, under high salt conditions the interaction between 
Np95-His and GFP-Dnmt1 was lost, while co-immunoprecipitation of GFP-Dnmt3a and 
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GFP-Dnmt3b1 remained relatively unaffected. These data clearly indicate that Np95 interacts 
with the de novo methyltransferases Dnmt3a and 3b even stronger than with Dnmt1. 
Np95 Mediates Epigenetic Silencing and Promoter de novo Methylation 
As DNA methylation plays a central role in epigenetic silencing we investigated the 
requirement of DNA methyltransferases and Np95 for promoter silencing in ESCs. To this aim 
we established an epigenetic silencing assay based on the observation that in ESCs the 
immediate-early CMV promoter is prone to silencing, while the chimeric CAG promoter is 
relatively refractory. ESCs were cotransfected with two distinct plasmids, one expressing 
monomeric red fluorescent protein (mRFP) under the CMV promoter, the other expressing 
GFP driven by the CAG promoter. mRFP and GFP expression was monitored for up to ten 
days after transfection by automated image acquisition and quantification of fluorescent 
signals (Supplementary Fig. S4A). The ratio between mRFP and GFP expression declined 
steadily in wild type ESCs, reflecting preferential silencing of the CMV promoter (Fig. 2). In 
contrast, dnmt3 DKO and dnmt1, 3a and 3b triple knockout (TKO) ESCs showed no 
preferential silencing of the CMV promoter. Surprisingly, np95-/- ESCs were also unable to 
silence the CMV promoter, while dnmt1-/- ESCs showed slower silencing kinetics than wild 
type cells, which is consistent with only partially reduced de novo methyltransferase activity in 
these cells (Lei et al., 1996). We could rule out potential artefacts arising from differences in 
GFP and mRFP stability or their coding sequences since the exchange of these reporters gave 
very similar results (Supplementary Fig. S4B). Thus, despite expressing a full complement of 
DNA methyltransferases, ESCs lacking Np95 are as deficient in promoter silencing activity as 
ESCs lacking all three major Dnmts. We next investigated whether silencing is accompanied 
by CpG methylation and detected substantial methylation in the CMV promoter ten days 
after transfection of wt, but not np95-/- ESCs (Fig. 3).  
These results show that not only DNA methyltransferases but also Np95 are required for de 
novo methylation and gene silencing. The interaction of Np95 with the regulatory domains of 
Dnmt3a and 3b described here suggests that Np95 may recruit and/or activate these de novo 
methyltransferases at target sites and thus mediate epigenetic silencing. Recent studies 
showed that the histone H3 lysine 9 methyltransferase (H3K9 MTase) G9a interacts with 
Dnmt3a and 3b and is also required for de novo methylation and stable silencing of 
promoters upon differentiation of ESCs (Dong et al., 2008; Epsztejn-Litman et al., 2008; 
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Feldman et al., 2006; Kim et al., 2008; Tachibana et al., 2008). This raises the question whether 
Np95 and G9a operate along the same pathway and how they both contribute in a non-
redundant fashion to de novo methylation and stable promoter silencing. Notably, the 
reporter gene expression in our assay steadily declined even before de novo methylation of 
the promoter was detected, arguing for an essential role of Np95 as well as the de novo 
Dnmts in early and late events of gene silencing (Fig. 2A, 3 and data not shown). Interestingly, 
Np95, Dnmt3a and 3b were all shown to interact with histone deacetylases (Fuks et al., 2001; 
Geiman et al., 2004; Unoki et al., 2004). In addition, an interaction between Np95 and G9a has 
been recently described and association of the de novo Dnmts with other H3K9 MTases had 
been previously reported (Fuks et al., 2003; Kim et al., 2008; Lehnertz et al., 2003; Li et al., 
2006). Thus, Np95 and de novo Dnmts may be required for histone deacetylation and/or 
H3K9 methylation at the onset of silencing. 
In summary, we show that Np95 interacts with the de novo DNA methyltransferases Dnmt3a 
and 3b and that Np95 and the de novo DNA methyltransferases are required for promoter 
silencing in ESCs. These data clearly support a role for Np95 in epigenetic silencing mediated 
by Dnmt3a and 3b and make Np95 an interesting target for epigenetic reprogramming. 
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METHODS 
Cell Culture and Transfection 
HEK293T cells, BHK cells and ESCs were cultured and transfected as described (Schermelleh et 
al., 2007), except FuGENE HD (Roche) was used for transfection of ESCs. The dnmt1-/- J1 ESCs 
used in this study are homozygous for the c allele (Lei et al., 1996). BHK cells were co-
transfected on glass coverslips with GFP-Dnmt3 and Cherry-Np95 constructs using 
Transfectin (Bio-Rad) according to the manufacturer’s instructions. Cell fixation and 
microscopy were carried out as described (Rothbauer et al., 2008). 
Co-Immunoprecipitation 
ESCs and HEK293T cell extracts were harvested in lysis buffer (20 mM Tris/HCl pH 7.5, 0.5 mM 
EDTA, 2 mM PMSF, 0.5% NP40) containing 150 or 300 mM NaCl (high salt condition) and 
diluted with lysis buffer without NP40. GFP nanotrap (Rothbauer et al., 2008) and a specific 
rabbit antiserum (Citterio et al., 2004) were used for immunoprecipitation of GFP fusions and 
endogenous Np95, respectively. GFP nanotrap and protein G beads (Sigma) were washed 
with dilution buffer containing increasing salt concentrations (150 and 300 mM or 300 and 
500 mM NaCl for the high salt condition) and resuspended in SDS-PAGE sample buffer. The 
following mouse monoclonal antibodies were used for immunoblotting: anti-His (C-term., 
Invitrogen), anti-Dnmt3a (clone 64B1446, Imgenex) and anti-Dnmt3b (clone 52A1018, 
Abcam). Np95 was detected with the same antiserum used for immunoprecipitation. HRP 
conjugated rabbit anti-mouse or goat anti-rabbit secondary antibodies (Sigma) and ECL Plus 
reagent (GE Healthcare) were used for detection. 
Silencing Assay 
ESCs were cotransfected with pCAG-eGFP-IB and pCMV-mRFP as described above and 
images from living cells were acquired at the indicated time points with an InCell Analyser 
1000 (GE Healthcare) using a 20x air-objective (NA = 0.45) and standard filter settings for GFP 
and RFP. 90-150 images were acquired for each channel using the same exposure time 
throughout the time course. Cells were passaged every second day and images were taken 4-
5 h after seeding. Images were analysed with ImageJ v1.42a software. To calculate fluorescent 
reporter expression pictures were processed using a Gaussian blur algorithm (radius (sigma) 
= 2) and a threshold for maximal signal and minimal background coverage was adjusted and 
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applied to each channel (Supplementary Fig. S4A). The threshold was converted into area 
selection and the total size of the selected area was measured. 
Bisulfite Sequencing of the CMV Promoter 
ESCs were transfected as for the silencing assay with pCAG-eGFP-IB and pCMV-mRFP and 
GFP positive cells were sequentially sorted with a FACS Vantage (Becton Dikinson) at day 6 
and 10 after transfection. After the last sorting genomic DNA was isolated with the QIAmp 
DNA Mini kit (Qiagen), bisulfite treated with the EZ DNA Methylation-Gold kit (Zymo 
research) and amplified with primers CMV-forward TGGGATTTTTTTATTTGGTAGT and 
CMV-reverse ATGGGAGTTTGTTTTGGTATTA primers, PCR fragments were cloned with 
StrataClone PCR cloning (Stratagene). Individual clones were sequenced at Eurofins MWG 
Operon. 
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Figure 1 
Np95 interacts with de novo methyltransferases Dnmt3a and 3b. (A) Co-immunoprecipitation 
of Dnmt3a and Dnmt3b isoforms with Np95 in wild type and np95 -/- E14 ESCs. 
(B) Fluorescent two-hybrid assay (F2H) shows recruitment of Cherry-Np95 (prey) at the lac 
operator array when GFP fusions of full length Dnmt3a and 3b1 (G-Dnmt3a/b fl) or their N-
terminal regions (G-Dnmt3a/b N) are used as baits and not with their isolated C-terminal 
catalytic domains (G-Dnmt3a/b C). Scale bars represent 5 µm. (C) Co-immunoprecipitation of 
Np95-His with GFP tagged Dnmt1, 3a and 3b1 (G-Dnmt) transiently co-expressed in HEK293T 
cells. Co-expression of GFP was used as control. In the upper row immunoprecipitations in 
the presence of 150 mM NaCl throughout the procedure are shown, while in the lower row 
immunoprecipitation and wash buffers contained 300 mM and the 500 mM NaCl, 
respectively. 2% of input (I) and supernatant (S) relative to bound (B) fractions were loaded in 
a and c.  
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Figure 2 
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Figure 2 
Promoter silencing activity in wild type, np95-/-, dnmt1-/- and TKO ESCs. Indicated ESC lines 
were transiently cotransfected with CMV promoter-driven mRFP and CAG promoter-driven 
GFP reporter constructs. Between 90 and 150 images per sample were acquired either every 
second day after transfection from a single experiment (A) or only at day 2 and 7-10 after 
transfection from 3-5 independent experiments. (B) Relative levels of red vs. green 
fluorescence are shown with values for day 2 (first day of imaging) set to 1. Wild type (wt) 
and dnmt3a-/-;3b-/- J1 cells (not shown) gave very similar results to wt E14 and TKO cells, 
respectively. (C) Representative images of wt and np95-/- E14 ESCs co-transfected as in A and 
B (upper panels) and respective heat map intensity plots (lower panels). The scale bar 
represents 15 µm. 
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Figure 3 
Methylation analysis of the CMV promoter 10 days after transfection of wt and np95 -/- ESCs. 
Total isolated DNA was subjected to bisulfite sequencing for the proximal part of the 
promoter. Sequences from individual clones are shown as lines with unmethylated and 
methylated CpG sites represented by open and solid circles, respectively. 
 
  
under revision at EMBO Reports 
 
 
94   
SUPPLEMENTARY INFORMATION 
 
 
Supplementary Figure 1 
Np95 interacts with de novo methyltransferases Dnmt3a and 3b. (A) Co-immunoprecipitation 
of endogenous Dnmt3a and Dnmt3b isoforms with GFP-Np95 transiently expressed in np95-/- 
ESCs. (B) Co-immunoprecipitation of endogenous Np95 with either GFP-Dnmt3a (upper 
panel) or GFP-Dnmt3b1 (lower panel) transiently expressed in dnmt3a-/;3b-/- ESCs. Transient 
expression of GFP was used as control. GFP and GFP fusions were immunoprecipitated with 
GFP nanotrap as in experiments shown in Fig. 1B. 2% of input (I) relative to bound (B) 
fractions was loaded in A and B. (C) Co-immunoprecipitation of endogenous ICBP90/UHRF1 
and DNMT3b in HEK293T cells. Antibodies to mouse proteins cross-react with the respective 
human homologues. 4% of input (I) relative to bound (B) fractions was loaded. 
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Supplementary Figure 2 
Mapping the interaction domains of Dnmt3a/b and Np95. (A) Schematic representation of 
GFP-Dnmt3a/b fusion constructs used for mapping the interaction site with Np95 (N-terminal 
GFP tag is not shown). (B) Co-immunoprecipitation of Np95-His with GFP-Dnmt3 constructs 
(G-3a/b) from extracts of transiently transfected HEK293T cells. (C) Schematic representation 
of Np95-His constructs used for mapping the interaction site with Dnmt3a/b. (D) Co-
immunoprecipitation of Np95-His domains shown in c with GFP-Dnmt3a/b constructs from 
extracts of transiently transfected HEK293T cells. G indicates the GFP fusion. 0,5% of input (I) 
and 40% of bound (B) fractions were loaded. PWWP, domain with conserved pro-trp-trp-pro 
motif; NLS, nuclear localization signal; PHD, plant homeo domain; Ubl, ubiquitin-like domain; 
SRA, set and ring associated domain; RING, really interesting new gene domain. Results of 
mapping are scored by + or -. 
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Supplementary Figure 3 
Relative stability of Np95 interactions with Dnmt1, 3a and 3b. The same blot as in Fig. 1b is 
shown here probed with an anti-GFP antibody to reveal that similar amounts of each GFP 
construct were immunoprecipitated in low and high salt conditions, indicating that binding of 
Np95 to Dnmt3a or 3b is more stable than that to Dnmt1. 
  
Fellinger et al. 2009 
 
 
  97 
 
 
Supplementary Figure 4 
(A) Automated procedure for quantification of fluorescent signals from digital micrographs 
for the promoter silencing assay. A macro was written for the ImageJ software that applies a 
Gaussian blur filter (left panel) and signal thresholding (right panel) to raw images (data not 
shown) and then calculates the total signal area. (B) Silencing assay results are not affected 
by the choice of fluorescent reporter. wt and np95-/- ESC were cotransfected with either CMV-
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driven mRFP and  CAG-driven GFP (red) or CAG-driven mRFP and CMV-driven GFP (blue) 
expression constructs and the ratio of CMV- over CAG-driven fluorescence was quantified at 
the indicated time points after transfection as for Figure 2A. 
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SUPPLEMENTARY METHODS 
Plasmid construction 
The CMV-driven enhanced GFP construct was from Clontech (pEGFP-C1). To generate the 
CMV-driven mRFP construct (pCMV-mRFP) the coding sequence for eGFP in pEGFP-C1 was 
replaced with that for mRFP from pRSETB-mRFP(Campbell et al., 2002) (provided by Roger 
Tsien). To create CAG-driven eGFP, mRFP and mCherry expression constructs (pCAG-eGFP-IB, 
pCAG-mRFP-IB and pCAG-mCherry-IB, respectively) sequences coding for the respective 
fluorescent proteins from pEGFP, pRSETB-mRFP and pRSETB-mCherry(Shaner et al., 2004) 
(also provided by R. Tsien) were inserted downstream to the CAG promoter in the pCAG-
IRESblast vector(Chen et al., 2003). The expression construct for Np95-His was described 
previously(Citterio et al., 2004). To generate expression constructs for GFP-Np95, Ch-Np95, 
GFP-Dnmt3a and GFP-Dnmt3b1 the sequences coding for Np95, Dnmt3a or Dnmt3b1 were 
then transferred from the respective CMV promoter-driven constructs(Chen et al., 2003; 
Citterio et al., 2004) to either pCAG-eGFP-IB or pCAG-mCherry-IB downstream to sequences 
coding for the fluorescent protein. GFP-Dnmt3a and GFP-Dnmt3b1 deletion constructs were 
generated by overlap extension mutagenesis(Ho et al., 1989) to remove the following amino 
acids from Dnmt3a and 3b1, respectively: 278-343 and 223-287 ∆PWWP); 485-582 and 435-
532 (∆PHD). GFP fusion constructs of N-terminal regions (aa 1-629 and 1-580) and C-terminal 
domains (aa 630-908 and 581-859) of Dnmt3a and 3b, respectively, were generated by PCR 
cloning using full length constructs as templates. All constructs were characterised by 
sequencing and immunoblotting. 
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3. Discussion 
3.1 Mutagenesis Strategies to Study Protein-Protein Interactions 
Mutagenesis is used to engineer proteins for an improved function and to investigate the 
contribution of single domains or amino acids to protein function. In general, there are two 
different approaches to address this issue, random and site-directed mutagenesis. Random 
mutagenesis can be applied for directed protein evolution by generating a library of protein 
variants using error-prone PCR and selecting candidates by screening for the improved 
function. We use site-directed mutagenesis to determine protein regions and amino acids 
that are crucial for protein-protein interactions. Recently, a Y2H based strategy to map 
interacting protein domains of Dnmt3a and Dnmt3L has been described. Protein variants of 
Dnmt3a were generated by random mutagenesis, 76 interacting variants were sequenced and 
aligned. The region that had no mutations acquired was taken as the interacting domain and 
therefore this approach was called “absence of interference”. The findings were confirmed by 
site-directed mutagenesis and structural analysis (Dhayalan et al., 2008). We are studying 
DNA methyltransferases in their native environment, in mammalian cells to account for 
posttranslational modifications that might be absent in yeast. In addition, our mutagenesis 
strategy (chapter 2.1) consists only of three simple steps and does not require cost-intensive 
sequencing of multiple clones for evaluation. 
As no structural information of Dnmt1 was available at that time to decide about target 
amino acids for mutagenesis, we headed for hydrophilic regions that are in general exposed 
at the surface of globular proteins and hence might be involved in protein-protein 
interactions. To determine such hydrophilic regions we generated a hydrophilicity plot of 
Dnmt1 using the Hopp and Woods algorithm (Hopp and Woods, 1981). A hydrophilicity 
value is assigned to every amino acid and average values are calculated for windows with 
selected size along the protein sequence. The hydrophilicity plot (Figure 3.1A) depicts the C-
terminal region of the TS domain, the peaks indicate hydrophilic regions. Based on this plot, 
we generated a deletion between the two hydrophilic peaks EDS and DDE (∆553-578). 
Recently, the structure of the human TS domain was solved (aa 351-600, PDB 3epz; (Walker, 
2008b)). Interestingly, the hydrophilic region that was deleted based on the hydrophilicity 
plot, forms a distinct α-helix as highlighted in the crystal structure (Figure 3.1B) and its 
deletion did not affect catalytic activity of Dnmt1 as determined with the trapping assay 
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((Schermelleh et al., 2005); chapter 2.1). In summary, based on secondary structure analysis 
we generated a deletion mutant where a distinct structural element was deleted and the 
overall protein folding was not disturbed. Comparison of the structure and the previously 
generated mutations provides new insights on potential binding surfaces and allows 
specifically targeted mutagenesis design in the future. 
 
Figure 3.1 Structural analysis of Dnmt TS domain. (A) Hydrophilicity plot (Hopp and Woods, 1981) of the C-terminal 
part of the TS domain (aa 550-629); a window size of six was applied using the linear weight variation model; peaks 
designate hydrophilic regions and respective amino acids are indicated; deletion (∆) is marked between two hydrophilic 
peaks: EDS-DDE (553-578). (B) Crystal structure of TS domain (PDB 3epz, (Walker, 2008b)). The deleted hydrophilic 
region is highlighted in orange and forms a distinct α-helix, a zinc-ion (gray ball) is complexed. The image was 
generated using the PyMOL software (DeLano, 2002). 
Various site-directed mutagenesis strategies and kits are available presenting different 
advantages and disadvantages. Our requirements were not only to develop a fast and robust 
strategy that allows inexpensive screening of clones but also a streamlined generation of 
point, deletion and insertion mutants that can be easily expanded. As none of the kits fulfilled 
all these requirements, we designed a novel alanine-scanning mutagenesis strategy that 
allows first, the generation of alanine substitution, deletion and insertion mutants of one 
protein in parallel, and second, introduces a restriction site (SacII or NotI) as marker for fast 
and inexpensive screening of mutant clones. Third, fast generation of a large toolbox of 
protein variants allows easy extension by swapping domains or different combination of 
insert fragments by cut and paste with the restriction sites introduced by the initial 
mutagenesis. Fourth, we are not limited to vectors with a maximal size of 8 kb as some 
commercial kits (Invitrogen, Genetailor) and successfully applied the strategy to larger vectors 
(about 10 kb). As we are extensively studying the protein family of DNA methyltransferases, 
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rapid enlargement of our set of mutants allows us to efficiently address new emerging 
questions with a tailored set of protein variants.  
 
 
 
  
The newly developed mutagenesis strategy offers a long term advantage for 
our analysis of Dnmts, without depending on expensive commercial kits and 
new mutagenesis design for each new question. 
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3.2 Biochemical Analysis of N-C Terminal Dnmt1 Interactions 
Dnmt1 is a large enzyme comprising 1620 amino acids and a molecular mass of 183 kDa. The 
regulatory N-terminal domain contains 1111 amino acids and several functional and only 
partially characterized subdomains. A glycine-lysine repeat linker (GK)7 connects the N-
terminal domain to the C-terminal catalytic domain. This linker provides conformational 
flexibility and allows dynamic interactions between catalytic C-terminal domain and the 
regulatory N-terminal domain that was reported to play a role in sequence specific DNA 
recognition by Dnmt1 (Bestor, 1992). The C-terminal catalytic domain contains all 
characteristic motifs known from bacterial methyltransferases. Bacterial methyltransferases do 
not have any separate regulatory domains but show sequence specific DNA recognition and 
methylation patterns. In contrast, the catalytic domain of Dnmt1 is not catalytically active per 
se (Fatemi et al., 2001; Margot et al., 2003; Zimmermann et al., 1997) but requires allosteric 
activation through the N-terminal regulatory domain (Bacolla et al., 1999). This complex 
regulatory domain and the linker connecting the two domains might account for various 
active and nonactive conformations of Dnmt1. So far, structural information of Dnmt1 is only 
available of a 250 aa region of the N-terminal domain corresponding to the TS domain (PDB: 
3epz (Walker, 2008b)), while structural information of other Dnmts that all contain smaller N-
terminal domains is already available: Dnmt2, 3a, 3b, 3L (Dong et al., 2001; Jia et al., 2007; Ooi 
et al., 2007; Qiu et al., 2002). To understand the N-C-terminal regulation of Dnmt1 we 
determined the minimal region of the N-terminus that is required for interaction with the 
catalytic domain. Only the N-terminal 309 amino acids were not necessary for the N-C 
terminal interaction. Neither the TS domain nor the BAH regions were dispensable for the 
interaction, nor were the individual domains sufficient to interact with the catalytic domain. 
These results indicate that the proper overall folding of the N-terminus is crucial for this 
interaction. Moreover, analysis of the Dnmt1 sequence and the intron-exon distribution 
revealed that Dnmt1 has evolved from the fusion of at least three genes (Margot et al., 2000). 
Dnmt1 N-terminus seems to be composed of originally two genes while the C-terminus 
corresponds to a third distinct gene and is very similar to the bacterial methyltransferases. 
Interestingly, the N-terminal region of 309 aa that are dispensable for the N-C terminal 
interaction and methyltransferase activity correspond well to one of the proposed ancestral 
genes. 
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3.2.1 Role of the Dnmt1 CXXC Zinc Finger for Catalytic Activity 
In addition, we assessed the role of the N-terminal CXXC zinc finger for the N-C-terminal 
interaction. Our results showed that the zinc finger (ZnF, aa 655-696) was dispensable for N-
C-terminal interaction of Dnmt1. Previously published data indicated that the zinc finger 
domain (aa 613-748) is even sufficient for interaction and allosteric activation of the catalytic 
domain and preferential recognition of methylated CpG DNA (Fatemi et al., 2001). The 
authors performed in vitro affinity purification to test Dnmt1 domain interactions using 
individual Dnmt1 domains recombinantly produced in E.coli. We addressed this question with 
a different strategy: Based on structural information of a very similar zinc finger from MLL 
(Allen et al., 2006) and by applying our versatile mutagenesis strategy, we concisely deleted 
the zinc finger without affecting surrounding protein regions (∆ZnF, ∆655-696). To test the 
interactions, N- and C-terminal domains of Dnmt1 were expressed in human cells (HEK293T) 
and co-immunoprecipitation experiments and immunoblotting were performed. Deletion of 
the ZnF from the N-terminus did not affect the N-C-terminal interaction. Moreover, GFP-
Dnmt1∆ZnF was tested for localization and catalytic activity in vivo and behaved like GFP-
Dnmt1 wt (unpublished data from A. Rottach). The differences between the results described 
by Fatemi et al. and our data might originate from major differences in the experimental 
setups: First, Fatemi et al. used a single zinc-binding domain (aa 613-748) that is larger than 
our deletion mutant lacking precisely the zinc-finger motif (aa 655-696). Second, they 
produced Dnmt1 domains in bacteria, where correct folding might be hampered due to a 
lack of distinct chaperone proteins or posttranslational modifications while we used a 
mammalian expression system. Third, the authors applied the domains to affinity purification 
to test interactions while we performed co-immunoprecipitation with cell extracts from 
human cells expressing N- and C-terminal Dnmt1 domains. 
A second, recent publication dealing with the Dnmt1 CXXC zinc finger indicated an essential 
role of the zinc finger domain for catalytic activity of Dnmt1 (Pradhan et al., 2008). Using gel-
shift assays of the recombinantly produced CXXC zinc finger domain (aa 645-737) from E.coli, 
binding to unmethylated CpG DNA was observed. In addition, mutation of cysteines in the 
zinc finger abolished DNA binding and Dnmt1 point and deletion mutants of the zinc finger 
(∆647-690) displayed reduced catalytic activity in a radioactive methyltransferase activity 
assay. Moreover, a stable conditional knock-in COS-7 cell line was generated, where the 
expression of Dnmt1∆647-690 was induced for 10 days and the methylation status of rDNA 
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repeat sequences, that are normally methylated, was assessed by bisulfate sequencing. As the 
authors observed a partial loss of rDNA methylation (25%) they proposed a dominant 
negative effect of Dnmt1∆647-690. 
Our data clearly indicate that the zinc finger does not play a role in N-C interaction, normal 
Dnmt1 activity was measured in vivo and in vitro (Frauer and Leonhardt, 2009; Schermelleh et 
al., 2005); unpublished data from A. Rottach and C. Frauer). In addition, the in vitro 
methyltransferase activity assay showed that GFP-Dnmt1∆655-696 had the same activity and 
preference for hemi-methylated DNA substrate as GFP-Dnmt1 wt. An in vitro DNA binding 
assay showed a preferential binding to unmethylated CpG sites for the ZnF domain (GFP-ZnF 
643-700, enriched from a HEK293T cell lysate). This is in line with the results from Pradhan et 
al. whereas as Fatemi et al. found the zinc finger domain preferential binding to methylated 
CpGs. Expression of human DNMT1∆647-690 in COS-7 cells (Pradhan et al., 2008) on top of 
the endogenous enzyme is artificial, causes elevated Dnmt1 levels and the endogenous 
protein might mask or influence the effect of the deletion mutant. As described in this work, 
Dnmt1 can form stable dimers, so that in case of this stable COS-7 cell lines chimeric Dnmt1 
dimers could be present. A better experiment to assess the function of the Dnmt1 zinc finger 
in vivo would be a rescue of dnmt1-/- ESCs with Dnmt1∆ZnF – and a characterization of that 
rescued cell line. Especially a quantitative methylation analysis of major and minor satellite 
sequences, retroviral elements such as IAPs and single copy genes should be performed by 
pyrosequencing. 
3.2.2 Role of Dnmt1 S515 Phosphorylation for Dnmt1 Activity 
Initially, Glickman et al identified serine 515 (S515) as major phosphorylation site of Dnmt1 by 
performing metabolic labeling and mass spectrometry (Glickman et al., 1997). A 
polymorphism in Dnmt1 aa F147 or aa SV 146-147 leads to serine numeration as S514 or 
S515. We work with the latter variant and therefore refer to the serine as S515. S515 is 
located in the center of the regulatory N-terminal domain of Dnmt1, within the TS domain 
that is indispensable for N-C-terminal interaction of Dnmt1. Therefore, we analyzed whether 
phosphorylation of S515 plays a role in the N-C terminal interaction and influences catalytic 
activity of Dnmt1. We used the phosphorylation mutants GFP-Dnmt1 and GFP-N-terminus 
S515A, where the phosphorylation site is eliminated (“P off”) and S515D mutants where 
aspartic acid mimics the phosphate group sterically and in charge distribution (“P on”) to 
study N-C-terminal interactions by co-immunprecipitation experiments. GFP-N-S515A 
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showed a comparable interaction with the catalytic domain as GFP-N wt while the S515D 
mutation weakened the N-C-terminal interaction. In addition, cell-cycle dependent 
localization of the mutants and catalytic activity in vivo and in vitro were tested and showed 
the same cellular distribution and catalytic activity as GFP-Dnmt1 wt (unpublished data from 
A. Rottach and C. Frauer). In summary, elimination of the S515 phosphorylation site did not 
have an impact on N-C-terminal interaction, localization and enzymatic activity of Dnmt1. 
However, using in vitro assays Goyal et al. found a role of serine 515 in activation of Dnmt1. 
Dnmt1 was purified from a baculovirus system and S515 phosphorylation was confirmed by 
mass spectrometry. Enzymatic activity of Dnmt1S515A and DnmtS515E (negatively charged 
glutamic acid to mimic phosphorylation) were compared to wildtype Dnmt1 by an in vitro 
activity assay using hemi-methylated DNA as substrate. In contrast to wildtype Dnmt1 (100% 
activity), Dnmt1S515E retained 73% activity but Dnmt1S515A showed only minimal activity 
(1.5%). As the N-C-terminal interaction is essential for Dnmt1 activity, the authors tested 
whether S515 phosphorylation influences catalytic activity. A phosphorylated peptide 
mimicking the region around S515 was tested as inhibitor of wildtype Dnmt1. Indeed, they 
observed a 10-fold stronger inhibition of Dnmt1 by the phosphorylated peptide as by the 
nonphosphorylated peptide (Goyal et al., 2007). Therefore the authors concluded that S515 
phosphorylation is important for activity of Dnmt1. 
The data presented in this work together with other data of our group clearly indicate that 
GFP-Dnmt1S515A is catalytically active and behaves like GFP-Dnmt1 wt with respect to 
normal N-C-terminal interaction, localization, activity in vivo and in vitro. The different results 
might be explained by the different experimental approaches. Goyal et al. performed 
exclusively in vitro studies with baculovirus expressed protein while our data where acquired 
by both, biochemical in vitro and cell-biological in vivo experiments analyzing Dnmt1 
expressed in mammalian cells. We used constructs with an N-terminal GFP-tag that allowed 
us to conduct with one tag both, biochemical assays with the GFP Nanotrap (Rothbauer et al., 
2008) and cell biological experiments. Normal enzymatic activity of GFP-tagged Dnmt1 has 
been shown previously (Spada et al., 2007). 
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To finally clarify the impact of S515 phosphorylation on Dnmt1 activity and methylation 
maintenance, a stable rescue of dnmt1-/- ESCs could be generated with Dnmt1S515A. A 
detailed characterization of the cell line, primarily of the methylation status of different types 
of sequences such as repetitive sequences, major and minor-satellite DNA, IAPs and single 
copy genes would answer the question whether deletion of the S515 phosphorylation site 
has an effect on Dnmt1 maintenance function. Moreover, a specific antibody against 
phosphorylated S515 could help to elucidate whether Dnmt1 phosphorylation is regulated in 
a cell-cycle dependent manner, as described for Dnmt1 localization. 
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3.3 The N-Terminal TS Domain Mediates Dnmt1 Dimerization 
Dimerization of C5 DNA methyltransferases has been described for bacterial and mammalian 
enzymes including HhaI, Dnmt3a and Dnmt3L (Dong et al., 2004; Jia et al., 2007). In this work, 
dimerization of Dnmt1 was shown (see chapter 2.3). In gelfiltration analyses of recombinant 
DNMT1, the enzyme presented the molecular weight of a dimer. Further investigations 
confirmed these observations and the Dnmt1 dimerization domain could be mapped by co-
immunoprecipitation experiments and the F2H assay to the N-terminal TS domain (aa 310-
629). Fine-mapping within the TS domain revealed a bipartite interaction surface between the 
two TS domains that is responsible for Dnmt1 dimerization (aa 310-410 and aa 476-502). The 
N-terminal domain allosterically activates the catalytic domain of Dnmt1 (Fatemi et al., 2001; 
Margot et al., 2003). Deletions within the TS domain most likely disrupt the structural 
integrity of the N-terminus and thus the required conformations for allosteric activation of 
the catalytic domain cannot be accomplished. Careful alanine scanning mutagenesis 
(Fellinger et al, 2008), substituting three adjacent amino acids to alanine in that region did 
not disrupt dimerization. Deletion of the dimerization region would require eliminating 
almost 200 amino acids (310-502) from the center of the N-terminal domain. Previous 
experiments have shown that deletions within the N-terminal domain abolished enzymatic 
activity of Dnmt1 (Fatemi et al., 2001; Margot et al., 2000; Zimmermann et al., 1997). Thus, 
with deletion mutagenesis it is not possible to pinpoint the functional consequences of the 
dimerization as deletions in the TS domain affect the enzyme folding and disrupt catalytic 
activity.  
 
 
 
  
In summary, the TS domain is a multifunctional key domain in Dnmt1 
regulation: First, it is required for N-C-terminal interaction and allosteric 
activation of the Dnmt1 catalytic domain and second, it recruits Dnmt1 to 
PH by interaction with Np95 (chapter 2.4). Third, the TS domain is 
responsible for Dnmt1 dimerization (chapter 2.3). 
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Interestingly, Dnmt3a dimerization is mediated by interactions between the catalytic domains 
and the interface (aa 806-880) is located very close to the catalytic center of the enzyme. 
Moreover, substitution of the key residues for dimerization R881 and D872 abolished 
catalytic activity of Dnmt3a, indicating that either the dimer conformation of Dnmt3a might 
be crucial for enzymatic activity or that disruption of the dimer interface that is close to the 
catalytic center affects proper folding of that region and therefore abolishes Dnmt3a activity. 
In contrast to Dnmt1 where the N-terminal multifunctional TS domain mediates dimerization, 
the N-terminal regulatory domains of Dnmt3a or 3L are not involved in dimer formation (Jia 
et al., 2007). Recently, first structural insights into the N-terminal region corresponding to the 
TS domain were gained (aa 351-600; PDB: 3epz; (Walker, 2008b)). Despite some flexible, 
unstructured regions the crystal structure shows that the conserved core region (aa 465-500) 
forms three consecutive beta sheets and builds a potential binding pocket in the center of 
the domain. Where this region is situated in the context of the full-length enzyme remains 
unclear. However, these first structural insights facilitate future mutagenesis approaches. 
Dnmt1 is a very complex enzyme, a large N-terminal regulatory domain is connected by a 
(GK)7 linker to the catalytic domain. This unique composition likely yields a variety of different 
conformations and could be one explanation for the limited success of Dnmt1 crystallization 
attempts so far, compared to other Dnmt members (Dong et al., 2001; Jia et al., 2007; Ooi et 
al., 2007; Qiu et al., 2002). Hence, a variety of intra- and intermolecular interactions of Dnmt1 
are responsible for the complex regulation of Dnmt1. In addition to dimerization, the TS 
domain contributes to allosteric activation of the catalytic domain (Fatemi et al., 2001; Margot 
et al., 2000; Zimmermann et al., 1997) and mediates association with pericentric 
heterochromatin by interaction with Np95 (Easwaran et al., 2004).  
 
 
 
 
  
Further studies are necessary to elucidate the temporal and spatial 
coordination of these multiple functions of the TS domain and to analyze 
whether Dnmt1 dimer formation facilitates the discrimination of hemi-
methylated CpG sites. 
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3.4 Np95 is a Key Regulator of DNA Methyltransferases 
Np95 was described to play a role in maintenance of DNA methylation patterns and to 
interact with Dnmt1 (Bostick et al., 2007; Sharif et al., 2007). Moreover, we found Np95 to be 
essential for gene silencing through de novo methylation by Dnmt3a and3b. We showed 
interaction of Np95 with the three major Dnmts Dnmt1, 3a and 3b by biochemical and cell 
biological experiments and mapped the interaction to the regulatory N-terminal domains of 
Dnmts (Figure 3.2). 
 
Figure 3.2 Summary of Dnmt-Np95 interacting domains. Schematic overview of Dnmts and Np95; PBD, PCNA binding 
domain; TS, targeting sequence; ZnF, zinc finger; BAH1+2, bromo adjacent homology domains 1+2, PWWP, pro-trp-trp-
pro motif, PHD, plant homeo domain; UBL, ubiquitin-like domain; TUDOR, tandem tudor domain; SRA, SET and RING 
associated domain; RING, really interesting new gene, containing ubiquitin E3 ligase activity. Black lines indicate the 
respective interacting domains between Dnmts and Np95, yellow box within the Dnmt1 TS domain highlights the major 
interaction site. 
While in Dnmt1 mainly the TS domain mediates the interaction, in Dnmt3a and 3b no distinct 
N-terminal subdomain such as PWWP or PHD was exclusively responsible for the interaction 
with Np95. Within Np95 we found the N-terminal domain containing the ubiquitin like-
domain and the tandem tudor domain to interact with Dnmt3a and 3b and the SRA domain 
as second binding interface. The Np95 interaction with Dnmt1 is exclusively mediated by the 
ubiquitin-like domain. Two recent publications describe Np95 as an essential factor for 
methylation maintenance by recruiting Dnmt1 to replication sites (Bostick et al., 2007; Sharif 
et al., 2007). By performing GST-pulldowns of purified protein domains from E. coli Bostick et 
al. found the PHD domain (aa 220-416) of human NP95 responsible for interaction with 
DNMT1 and the N-terminal region 1-446 and C-terminal region 1081-1408 of DNMT1 
interacting with NP95. Achour et al. identified in an Y2H screen an N-terminal region 
corresponding to the TS domain (406-615) to interact with the SRA domain (357-635) of 
NP95 (Achour et al., 2008) which corresponds to our data of the TS domain as major 
interaction site of Dnmt1. In addition, our data showed that even a single point mutation 
within the TS domain (G474E) strongly impaired the interaction with Np95, while deletion of a 
highly conserved stretch of amino acids (459-501) completely abolished the interaction. 
The Np95 interaction mutant GFP-Dnmt1∆459-501 localized at replication sites during early- 
and mid-S phase and showed a higher diffuse fraction in late S-phase. These results indicated 
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that Dnmt1 can normally interact with the replication platform PCNA while the interaction 
with Np95 that is essential for directing Dnmt1 to pericentric heterochromatin (PH) in late S-
phase was abolished. The cell-cycle dependent localization of Dnmt1 is summarized in Figure 
3.3. 
 
Figure 3.3 Overview of GFP-Dnmt1 domain structure. Depicted in green is a N-terminal GFP that was used to visualize 
Dnmt1 by fluorescence microscopy. PBD, PCNA binding domain; TS, targeting sequence; ZnF, zinc finger; BAH1+2, 
bromo adjacent homology domains 1+2, methyltransferase motifs I-X. Cell cycle stages are indicated at the bottom. 
Interaction with PCNA directs Dnmt1 to the replication machinery from early to late S phase; from late S phase into 
M/G2 Np95 interaction targets Dnmt1 to pericentric heterochromatin, indicated by the blue arrows. Dnmt1 has several 
DNA binding sites but DNA binding through the catalytic domain is specific for hemi-methylated DNA. A grey arrow 
points out the interaction between the regulatory N-terminal and the catalytic C-terminal domain that is necessary for 
allosteric activation of Dnmt1. 
We found the Np95 interaction mutant GFP-Dnmt1∆459-501 to behave with an 
approximately two-fold slower kinetics than GFP-Dnmt1 wt in the in vivo trapping assay in 
C2C12 mouse myoblast cells (Schermelleh et al., 2005). The trapping assay is based on the 
incorporation of the cytosine analogue 5-aza-dC into the DNA. Dnmt1 molecules that are 
capable to form a covalent complex with this base analogue are trapped at their target sites 
as this complex cannot be resolved. This accumulation can be visualized by fluorescence 
microscopy and FRAP analysis. Moreover, GFP-Dnmt1∆459-501 showed normal activity in a 
radioactive methyltransferase activity assay using hemi-methylated oligonucleotide DNA as 
substrate.  
 
 
 
  
This result indicates that the deletion did not disrupt the overall protein 
structure and that GFP-Dnmt1∆459-501 was able to methylate
 “naked” DNA. 
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Interestingly, stable expression of GFP-Dnmt1∆459-501 in dnmt1-/- ESCs failed to restore 
DNA methylation at different types of sequences, major and minor satellite DNA, IAPs and 
single copy genes (unpublished pyrosequencing data from W. Qin). The differing results of 
the trapping assay and ESC methylation rescue experiment might be due to the different 
experimental setups: First, the trapping assay was performed by measuring the covalent 
complex formation of GFP-Dnmt1∆459-501 in somatic cells that contain normal levels of 
endogenous Dnmt1. Upon the formation of Dnmt1 dimers – a mutant and an endogenous wt 
molecule could form a chimeric complex, interact with Np95, thereby access its target sites in 
DNA and hence account for the accumulation of GFP-Dnmt1∆459-501 at RF. Second, we 
analyzed the cells only during S phase in the presence of elevated levels of GFP-Dnmt1 and 
the interactor RFP-PCNA that were both over-expressed. In addition, the cells contained a 
high concentration of the trapping substrate 5-aza-dC (30 μM). Third, the trapping assay was 
performed in somatic cells while the rescue experiments were carried out in ESCs. In dnmt1-/- 
ESCs is no background level of endogenous Dnmt1 as in the somatic myoblast cells used for 
the trapping assay. Moreover, there might be different pathways active that change from 
undifferentiated ESCs during differentiation to somatic cells. 
In contrast, rescue of dnmt1-/- ESCs analyzed and compared the behavior of the Dnmt1 
mutant and wt in vivo, the only difference to wt ESCs is a lower DNA methylation level in this 
cell line. Moreover, stably expressing GFP-Dnmt1∆459-501 ESCs with Dnmt1 protein levels 
corresponding to endogenous Dnmt1 levels were selected. However, GFP-Dnmt1∆459-501 
failed to re-methylate the DNA while GFP-Dnmt1 wt succeeded. This loss of function 
suggests that the interaction with Np95 might be necessary in vivo to direct Dnmt1 to its 
target sites and / or facilitate its access.  
 
 
  
Taken together, deletion of the 42 amino acids within the TS domain that 
are crucial for interaction with Np95, lead to normal Dnmt1 activity in vitro 
but not in vivo. In line with previously published data, our results lead to the 
conclusion that the interaction with Np95 is indispensable for proper 
methylation maintenance function of Dnmt1 as it is also reflected by the 
low methylation levels in np95-/- ESCs that phenocopy the dnmt1-/- ESCs. 
Further investigations are necessary to find out whether Np95 opens the 
chromatin for Dnmt1 accessibility. 
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As the PHD domain of Np95 was described to open chromatin in chromocenters (Papait et 
al., 2008) one could rescue np95-/- ESCs with Np95 mutants (∆PHD) and analyze the effect of 
potentially missing chromatin remodeling activity of Np95 on DNA methylation. Moreover, 
an in vitro Dnmt1 methyltransferase activity test could be performed using nucleosomal 
hemi-methylated DNA as substrate in the presence and absence of Np95. This experiment 
could show whether a potential remodeling activity of Np95 enables Dnmt1 to access a 
target CpG site in chromatin. 
 
Structural analyses of the SRA domain indicated that binding of Np95 to hemi-methylated 
DNA would block the target strand for methylation (Arita et al., 2008; Avvakumov et al., 2008; 
Hashimoto et al., 2008). Therefore, Np95 might target Dnmt1 to a hemi-methylated DNA 
region where the enzyme could then find other hemi-methylated sites by linear diffusion on 
DNA. Further dissociation of Np95 from the DNA could then make the site accessible for 
Dnmt1 (Jeltsch, 2008). Such a mechanism could account for the high accuracy of Dnmt1 
mediated methylation as the Np95 mark on DNA could be recognized by Dnmt1 more 
efficiently than a hemi-methylated cytosine in the DNA helix that might be masked by 
chromatin and chromatin binding proteins. In addition, Np95 might open up the chromatin 
for accessibility of DNA methyltransferases. As both, Np95 and Dnmt1 have a preference for 
hemi-methylated DNA this could be a synergistic targeting mechanism to ensure proper 
maintenance of methylation in vivo. 
 
We also found, that Np95 interacts with de novo methyltransferases Dnmt3a and 3b and that 
these interactions are even stronger than with Dnmt1. Moreover, we observed that Np95 is 
essential in epigenetic silencing. The role of Np95 in epigenetic transgene silencing was 
investigated in wt and np95-/- ESCs using a CMV driven fluorescent reporter gene (Fellinger et 
al, under review at EMBO Reports, silencing assay data from D. Meilinger and S. Bultmann). 
The decrease of the CMV promoter driven reporter gene expression was normalized to a 
chicken β-actin (CAG) promoter driven reporter gene. As the latter originates from a house 
keeping gene and contains a CpG-island, it is protected from silencing. The CMV reporter 
gene expression was epigenetically silenced by de novo DNA methylation after 10 days in wt 
ESCs and with a slower silencing kinetics in dnmt1-/- ESCs whereas in np95-/- and TKO ESCs 
(that are deficient in Dnmt1, 3a and 3b) no silencing was observed. Despite the presence of 
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all Dnmts transgene expression was not silenced in np95-/- ESCs and no methylation was 
detected.  
 
Besides binding to hemi-methylated DNA, Np95 was shown to interact with chromatin 
proteins (Citterio et al., 2004; Hashimoto et al., 2009; Karagianni et al., 2008; Papait et al., 
2007), and specifically with trimethylated H3K9 through its tandem tudor domain (PDB: 3db3; 
(Walker, 2008a)) and to posses some sort of remodeling activity through its PHD domain 
(Papait et al., 2008). The H3K9 methyltransferase G9a was reported to be required for de novo 
methylation independent of its histone methyltransferase activity and to recruit Dnmt3a and 
3b to promoter sequences in differentiating ESCs (Epsztejn-Litman et al., 2008). In addition, 
an interaction between Np95 and G9a was published recently, indicating that Np95 might 
recruit G9a to promoter regions to regulate transcription (Kim et al., 2008) or vice versa. 
Future investigations to elucidate the order of events in endogenous gene silencing should 
be undertaken. One possibility would be to differentiate various ESC lines (dnmt1-/-, np95 -/-, 
dnmt3a-/- 3b-/-, TKO, g9a-/-,,wt) and to perform chromatin immunoprecipitations (e.g. anti 
Np95, anti G9a or anti 5mC) from different time points during differentiation. The protein 
complexes bound to chromatin should be analyzed by mass spectrometry and in addition 
promoter methylation should be checked by bisulfate sequencing of genes that are down 
regulated during ESC differentiation such as Oct4 or Nanog. 
 
  
These results indicate that Np95 also plays a major role in epigenetic gene 
silencing mediated by de novo methylation through Dnmt3a and 3b. The 
interaction of Np95 with the regulatory N-terminal domains of Dnmt3a and 
3b described in this work suggests that Np95 might recruit de novo 
methyltransferases to target sites, possibly activates them and hence 
controls epigenetic silencing by de novo DNA methylation. 
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In summary, with Np95 we found a key regulatory factor that controls de 
novo and maintenance DNA methylation in embryonic stem cells by 
interaction with the de novo DNA methyltransferases Dnmt3a and 3b and 
the maintenance methyltransferase Dnmt1. We showed that both, Np95 
and the de novo DNA methyltransferases are required for transgene 
promoter silencing in ESCs. These data clearly support a role for Np95 in 
epigenetic silencing and make it an interesting target for epigenetic 
reprogramming. 
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4.4 Abbreviations 
5-aza-dC 5-aza-2'-deoxycytidine 
5mC 5 methyl-cytosine 
aa amino acids 
amp ampicilline 
B2H bacterial two-hybrid 
BAH bromo adjacent homology domain 
BiFC bimolecular flouresence complementation 
blast blasticidine 
CAG chicken beta actin 
CFP cyan fluorescent protein 
CGBP CpG binding protein 
CMT C-terminus of DNA methyltransferase 
CMV cytomegalie virus 
CpG cytosine-phosphatidyl-guanine 
DAPI 4’,6-diamidino-2’-phenylindole dihydrochloride 
dC deoxycytidine 
DMR differentially methylated region 
Dnmt DNA methyltransferase 
DRM2 domains rearranged methylase 2 
ESCs ES cells 
ESI electrospray ionization 
F2H fluorescence two-hybrid 
FRAP fluorescence recovery after photo bleaching 
FRET fluorescence resonance energy transfer 
GBP GFP binding protein 
genet geneticine 
GFP green fluorescent protein 
GST gluthathione-S-transferase 
HDACs histone deacetylases 
HP1 heterochromatin protein 1 
IAP intracisternal A-type particle 
ICF immunodeficiency, centromere instability and facial anomalies 
IPS induced pluripotent stem cell 
kana kanamycine 
MBD methyl CpG binding domain 
MeCP2 Methyl CpG binding protein 2 
MLL mixed lineage leukemia 
MT methyltransferase 
mRFP monomeric red fluorescent protein 
MS mass spectrometer 
neo neomycine 
NLS nuclear localization signal 
NMT N-terminus of DNA methyltransferase 
NMR nuclear magnetic resonance  
Np nuclear protein 
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Orc1p origin recognition complex 1 
p plasmid 
PAGE polyacrylamide gelelectrophoresis 
PBD PCNA binding domain 
pc plasmid collection 
PCNA proliferating cell nuclear antigen 
PCR polymerase chain reaction 
PDB Protein Data Bank 
PH pericentic heterochromatin 
PHD plant homeo domain 
PWWP proline-tryptophane-tryptophane-proline motif 
RF replication foci 
RING really interesting new gene 
SAM S-adenosyl-L-methionine 
SDM site-directed mutagenesis 
SDS sodium dodecylsulfate 
SETDB1 suppressor of variegation, enhancer of zeste and trithorax domain bifurcated 1 
Sirp1 silent information regulator 1 
SPR surface plasmon resonance 
SRA SET and RING associated domain 
SUV39H1 suppressor of variegation 3-9 homolog 1 
TKO dnmt1-/-3a-/-3b-/- triple knockout ESCs 
TLR 9 toll-like receptor 9 
tRNAAsp transfer ribonucleic acid for aspartic acid 
TS targeting sequence 
UAS upstream activator sequence 
UBL ubiquitin-like domain 
UHRF1 ubiquitin-like, containing PHD and RING finger domains 1 
wt wildtype 
Y2H yeast two-hybrid 
YFP yellow fluorescent protein 
ZnF zinc finger 
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4.5 List of Expression Constructs 
Table 4.1 All expression constructs that were cloned during this work are listed. Nomenclature: pc, plasmid collection; p, 
plasmid, eG, eGFP; Ch, Cherry; CMT, C-terminus of Dnmt; NMT, N-terminus of Dnmt; numbers indicate amino acid 
positions; V, version; NLS, nuclear localization signal; CAG, chicken beta-actin promoter; PHD, plant homeo domain; 
PWWP, pro-trp-trp-pro motif containing domain; MT, methyltransferase; kana, kanamycine, neo, neomycine; genet; 
geneticine, amp, ampicilline, blast, blasticidine. Plasmids generated by PCR were confirmed by DNA sequencing. A 
detailed description of these plasmids was entered in the laboratory information database and is available upon request. 
pc number Dnmt1 Restriction sites used
for cloning 
Antibiotic 
resistances 
1376 pChmCMT1his(1124-1620) BsrGI, XbaI kana, neo, genet 
1377 peGNMT1(1-1111) BsrGI, HindIII kana, neo, genet 
1431 peGNMT1(1-309) BsrGI, HindIII kana, neo, genet 
1432 peGNMT1(630-1111) BsrGI, HindIII kana, neo, genet 
1454 peGMT1L_V2 Oligo replaced linker kana, neo, genet 
1455 peGMT1L_V3 Oligo replaced SacII 
site 
kana, neo, genet 
1456 peGNMT1(1-1111)V2 Oligo replaced SacII 
site 
kana, neo, genet 
1481 peGMT1L_EDS553AAA SalI, BglII kana, neo, genet 
1482 peGMT1L_VVS563AAA SalI, BglII kana, neo, genet 
1489 peGMT1L_TTT622AAA SalI, BglII kana, neo, genet 
1491 peGNMT1_EDS553AAA SalI, BglII kana, neo, genet 
1492 peGNMT1_VVS563AAA SalI, BglII kana, neo, genet 
1493 peGNMT1_DDE576AAA SalI, BglII kana, neo, genet 
1494 peGNMT1_CMR586AAA SalI, BglII kana, neo, genet 
1495 peGNMT1_GVS595AAA SalI, BglII kana, neo, genet 
1496 peGNMT1_GQR599AAA SalI, BglII kana, neo, genet 
1497 peGNMT1_RRV605AAA SalI, BglII kana, neo, genet 
1498 peGNMT1_KAP616AAA SalI, BglII kana, neo, genet 
1514 peGMT1L_dEDS-DDE XhoI, SacII, XmaI kana, neo, genet 
1515 peGMT1L_dVVS-DDE XhoI, SacII, XmaI kana, neo, genet 
1593 peGMT1L S515A SalI, BglII kana, neo, genet 
1594 peGMT1L S515D SalI, BglII kana, neo, genet 
1595 peGNMT1(1-1111) S515A SalI, BglII kana, neo, genet 
1596 peGNMT1(1-1111) S515D SalI, BglII kana, neo, genet 
1637 peGNMT1(1-1111)ENP451AAA XhoI, SacII, XmaI kana, neo, genet 
1638 peGNMT1(1-1111)GEK478AAA XhoI, SacII, XmaI kana, neo, genet 
1639 peGNMT1(1-1111)SKE498AAA XhoI, SacII, XmaI kana, neo, genet 
1671 peGNMT1(1-1111)SKi515AAA XhoI, SacII, XmaI kana, neo, genet 
1672 peGNMT1(1-1111)EDL531AAA XhoI, SacII, XmaI kana, neo, genet 
1673 peGNMT1(1-1111)d478-498 XhoI, SacII, XmaI kana, neo, genet 
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pc number Dnmt1 TS domain Restriction sites 
used for cloning 
Antibiotic 
resistances 
1375 pChmTShis(310-629) BsrGI, XbaI kana, neo, gene 
1433 peGmTS(309-410) BsrGI, HindIII kana, neo, genet 
1434 peGmTS(411-523) BsrGI, HindIII kana, neo, genet 
1435 peGmTS(524-629) BsrGI, HindIII kana, neo, genet 
1442 pNLSeGmTS_EDS553AAA XhoI, SacII, XmaI kana, neo, genet 
1443 pNLSeGmTS_GQR599AAA XhoI, SacII, XmaI kana, neo, genet 
1444 pNLSeGmTS_GVS595AAA XhoI, SacII, XmaI kana, neo, genet 
1445 pNLSeGmTS_KAP616AAA XhoI, SacII, XmaI kana, neo, genet 
1446 pNLSeGmTS_RRV605AAA XhoI, SacII, XmaI kana, neo, genet 
1447 pNLSeGmTS_TTT622AAA XhoI, SacII, XmaI kana, neo, genet 
1448 pNLSeGmTS_VVS563AAA XhoI, SacII, XmaI kana, neo, genet 
1449 pNLSeGmTS_CMR586AAA XhoI, SacII, XmaI kana, neo, genet 
1508 peGmTS dEDS-VVS(553-565) XhoI, SacII, XmaI kana, neo, genet 
1509 peGmTS dEDS-DDE(553-578) XhoI, SacII, XmaI kana, neo, genet 
1511 peGmTS dEDS-CMR(553-588) XhoI, SacII, XmaI kana, neo, genet 
1512 peGmTS dVVS-CMRS(563-578) XhoI, SacII, XmaI kana, neo, genet 
1513 peGmTS_DDE576AAA XhoI, SacII, XmaI kana, neo, genet 
1531 pChmTS_EDS553AAA XhoI, SacII, XmaI kana, neo, genet 
1532 pChmTS_VVS563AAA XhoI, SacII, XmaI kana, neo, genet 
1533 pChmTS_DDE576AAA XhoI, SacII, XmaI kana, neo, genet 
1534 pChmTS_CMR586AAA XhoI, SacII, XmaI kana, neo, genet 
1541 peGmTS(310-629) XhoI, XmaI kana, neo, genet 
1542 peGmTS(310-588) XhoI, XmaI kana, neo, genet 
1543 peGmTS(310-550) XhoI, XmaI kana, neo, genet 
1544 peGmTS(310-502) XhoI, XmaI kana, neo, genet 
1545 peGmTS(361-629) XhoI, XmaI kana, neo, genet 
1546 peGmTS(410-629) XhoI, XmaI kana, neo, genet 
1547 peGmTS(475-629) XhoI, XmaI kana, neo, genet 
1548 peGmTS(310-629)EDS553AAA XhoI, SacII, XmaI kana, neo, genet 
1549 peGmTSdEDS-DDE(310-629) XhoI, SacII, XmaI kana, neo, genet 
1581 peGmTSdVVS-CMR(310-629) XhoI, SacII, XmaI kana, neo, genet 
1588 peGmTS(310-475) XhoI, XmaI kana, neo, genet 
1589 peGmTS(310-409) XhoI, XmaI kana, neo, genet 
1591 peGmTS(503-629) XhoI, XmaI kana, neo, genet 
1592 peGmTS(551-629) XhoI, XmaI kana, neo, genet 
1601 peChmTS(310-550) XhoI, XmaI kana, neo, genet 
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1602 peChmTS(310-502) XhoI, XmaI kana, neo, genet 
1603 peChmTS(410-629) XhoI, XmaI kana, neo, genet 
1604 peChmTS(476-629) XhoI, XmaI kana, neo, genet 
1605 peChmTS(310-475) XhoI, XmaI kana, neo, genet 
1606 peChmTS(310-409) XhoI, XmaI kana, neo, genet 
1607 peChmTS(503-629) XhoI, XmaI kana, neo, genet 
1608 peChmTS(551-629) XhoI, XmaI kana, neo, genet 
1609 peGmTS(310-629) DER315AAA XhoI, SacII, XmaI kana, neo, genet 
1611 peGmTS(310-629) SER340AAA XhoI, SacII, XmaI kana, neo, genet 
1612 peGmTS(310-629) EDA378AAA XhoI, SacII, XmaI kana, neo, genet 
1613 peGmTS(310-629) EDS406AAA XhoI, SacII, XmaI kana, neo, genet 
1614 peGmTS(310-629) EKN435AAA XhoI, SacII, XmaI kana, neo, genet 
1615 peGmTS(310-629)ENP451AAA XhoI, SacII, XmaI kana, neo, genet 
1617 peGmTS(310-629)SKE498AAA XhoI, SacII, XmaI kana, neo, genet 
1618 peGmTS(310-629)SKI515AAA XhoI, SacII, XmaI kana, neo, genet 
1619 peGmTS(310-629)EDL531AAA XhoI, SacII, XmaI kana, neo, genet 
1621 peGmTS(310-629)d478-498 XhoI, SacII, XmaI kana, neo, genet 
1675 pChmTS(310-629)d478-498 XhoI, SacII, XmaI kana, neo, genet 
 
pc number Dnmt3a Restriction sites 
used for cloning 
Antibiotic 
resistances 
1749 pCAG-eGMT3a2 AsiSI, NotI amp, blast 
1831 pCAG-eGMT3a dPWWP AsiSI, NotI amp, blast 
1832 pCAG-eGMT3a dPHD AsiSI, NotI amp, blast 
1833 pCAG-eGMT3a 1-629 AsiSI, NotI amp, blast 
1834 pCAG-eGMT3a 630-908 AsiSI, NotI amp, blast 
 
pc number Dnmt3b Restriction sites 
used for cloning 
Antibiotic 
resistances 
1751 pCAG-eGMT3b6 AsiSI, NotI amp, blast 
1752 pCAG-eGMT3b7 AsiSI, NotI amp, blast 
1753 pCAG-eGMT3b8 AsiSI, NotI amp, blast 
1835 pCAG-eGMT3b dPWWP AsiSI, NotI amp, blast 
1836 pCAG-eGMT3b dPHD AsiSI, NotI amp, blast 
1837 pCAG-eGMT3b 1-584 AsiSI, NotI amp, blast 
1838 pCAG-eGMT3b 585-863 AsiSI, NotI amp, blast 
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